: The AMEDEO Literature Guide

Home The Word Brain

My Amedeo

FAQ

Privacy

About

Flying Publisher

COVID-19: Daily Top 10 Papers

Nuclear Medicine

Free Subscription

Articles published in J Nucl Med
Retrieve available abstracts of 467 articles:
HTML format

Single Articles

November 2021

COSTA GCA, Spencer BA, Omidvari N, Foster C, et al
Radioembolization Dosimetry with Total-Body (90)Y PET.
J Nucl Med. 2021 Nov 18. pii: jnumed.121.263145. doi: 10.2967/jnumed.121.263145.
PubMed Abstract available

WANG G, Nardo L, Parikh M, Abdelhafez YG, et al
Total-Body PET Multiparametric Imaging of Cancer Using a Voxel-wise Strategy of Compartmental Modeling.
J Nucl Med. 2021 Nov 18. pii: jnumed.121.262668. doi: 10.2967/jnumed.121.262668.
PubMed Abstract available

MALPETTI M, Kaalund SS, Tsvetanov KA, Rittman T, et al
In vivo (18)F-flortaucipir PET does not accurately support the staging of progressive supranuclear palsy.
J Nucl Med. 2021 Nov 18. pii: jnumed.121.262985. doi: 10.2967/jnumed.121.262985.
PubMed Abstract available

THEISEN AL, Lassmann M, Tran-Gia J
Towards a patient-specific traceable quantification of SPECT/CT-based radiopharmaceutical distributions.
J Nucl Med. 2021 Nov 18. pii: jnumed.121.262925. doi: 10.2967/jnumed.121.262925.
PubMed Abstract available

REDDY RP, Schmidtlein CR, Giancipoli RG, Mauguen A, et al
The quest for an accurate functional tumor volume with (68)Ga-DOTATATE PET/CT.
J Nucl Med. 2021 Nov 12. pii: jnumed.121.262782. doi: 10.2967/jnumed.121.262782.
PubMed Abstract available

STELLA M, van Rooij R, Lam M, de Jong H, et al
Lung dose measured on post-radioembolization (90)Y-PET/CT and incidence of radiation pneumonitis.
J Nucl Med. 2021 Nov 12. pii: jnumed.121.263143. doi: 10.2967/jnumed.121.263143.
PubMed Abstract available

SHAGERA QA, Artigas C, Karfis I, Critchi G, et al
(68)Ga-PSMA PET/CT for response assessment and outcome prediction in metastatic prostate cancer patients treated with taxane-based chemotherapy.
J Nucl Med. 2021 Nov 12. pii: jnumed.121.263006. doi: 10.2967/jnumed.121.263006.
PubMed Abstract available

MONA CE, Benz MR, Hikmat F, Grogan TR, et al
Correlation of (68)Ga-FAPi-46 PET biodistribution with FAP expression by immunohistochemistry in patients with solid cancers: a prospective translational exploratory study.
J Nucl Med. 2021 Nov 5. pii: jnumed.121.262426. doi: 10.2967/jnumed.121.262426.
PubMed Abstract available

BRADSHAW TJ, Boellaard R, Dutta J, Jha AK, et al
Nuclear Medicine and Artificial Intelligence: Best Practices for Algorithm Development.
J Nucl Med. 2021 Nov 5. pii: jnumed.121.262567. doi: 10.2967/jnumed.121.262567.
PubMed Abstract available

YOUNIS MH, Lan X, Cai W
PET with a (68)Ga-labeled FAPI dimer: moving towards theranostics.
J Nucl Med. 2021 Nov 5. pii: jnumed.121.263292. doi: 10.2967/jnumed.121.263292.
PubMed

THUILLIER P, Liberini V, Grimaldi S, Rampado O, et al
Prognostic value of whole-body PET volumetric parameters extracted from (68)Ga-DOTATOC-PET/CT in well-differentiated neuroendocrine tumors.
J Nucl Med. 2021 Nov 5. pii: jnumed.121.262652. doi: 10.2967/jnumed.121.262652.
PubMed Abstract available

KESNER AL
Commercially competitive vendor-agnostic image reconstruction could be a leap forward for PET harmonization.
J Nucl Med. 2021 Nov 5. pii: jnumed.121.263421. doi: 10.2967/jnumed.121.263421.
PubMed

SCOTT AM, Czernin J
Perspectives on Theranostics and Nuclear Medicine: A Conversation Between Andrew Scott and Johannes Czernin.
J Nucl Med. 2021;62:1492-1494.
PubMed

CALAIS J, Czernin J
PSMA Expression Assessed by PET Imaging Is a Required Biomarker for Selecting Patients for Any PSMA-Targeted Therapy.
J Nucl Med. 2021;62:1489-1491.
PubMed

PARKER MFL, Blecha J, Rosenberg O, Ohliger M, et al
Cyclic (68)Ga-Labeled Peptides for Specific Detection of Human Angiotensin-Converting Enzyme 2.
J Nucl Med. 2021;62:1631-1637.
PubMed Abstract available

October 2021

YUSUFALY T, Zou J, Nelson T, Williamson C, et al
Improved Prognosis of Treatment Failure in Cervical Cancer with Non-Tumor Positron Emission Tomography / Computed Tomography Radiomics.
J Nucl Med. 2021 Oct 28. pii: jnumed.121.262618. doi: 10.2967/jnumed.121.262618.
PubMed Abstract available

AHLMAN MA, Maass-Moreno R, Grayson PC peter.gray
Reply LTE, On Semi-quantitative Methods for Assessing Vascular (18)FDG-PET Activity in Large-Vessel Vasculitis.
J Nucl Med. 2021 Oct 28. pii: jnumed.121.263158. doi: 10.2967/jnumed.121.263158.
PubMed

BURGGRAAFF CN, Eertink JJ, Lugtenburg PJ, Hoekstra OS, et al
(18)F-FDG PET improves baseline clinical predictors of response in diffuse large B-cell lymphoma: The HOVON-84 study.
J Nucl Med. 2021 Oct 21. pii: jnumed.121.262205. doi: 10.2967/jnumed.121.262205.
PubMed Abstract available

GHEYSENS O, Belkhir L, Jamar F
Imaging in Post-COVID Lung Disease (PCLD): does [(18)F]-FDG-PET/CT have the Key?
J Nucl Med. 2021 Oct 21. pii: jnumed.121.263166. doi: 10.2967/jnumed.121.263166.
PubMed

LASNON C, Girault G, Lebtahi R, Ansquer C, et al
Women Authors in Nuclear Medicine Journals: a Survey from 2014 to 2020.
J Nucl Med. 2021 Oct 21. pii: jnumed.121.262773. doi: 10.2967/jnumed.121.262773.
PubMed Abstract available

SCHMIDKONZ C
Perspective on Fibroblast Activation Protein Specific PET/CT Imaging in Fibrotic Interstitial Lung Diseases: Imaging Fibrosis - a New Paradigm for Molecular Imaging?
J Nucl Med. 2021 Oct 14. pii: jnumed.121.262944. doi: 10.2967/jnumed.121.262944.
PubMed

SONNI I, Felker ER, Lenis AT, Sisk AE, et al
Head-to-head comparison of (68)Ga-PSMA-11 PET/CT and mpMRI with histopathology gold-standard in the detection, intra-prostatic localization and local extension of primary prostate cancer: results from a prospective single-center imaging trial.
J Nucl Med. 2021 Oct 14. pii: jnumed.121.262398. doi: 10.2967/jnumed.121.262398.
PubMed Abstract available

RISCHKA L, Vraka C, Pichler V, Rasul S, et al
First-in-human brain PET imaging of the GluN2B-containing N-methyl-D-aspartate receptor with (R)-(11)C-Me-NB1.
J Nucl Med. 2021 Oct 7. pii: jnumed.121.262427. doi: 10.2967/jnumed.121.262427.
PubMed Abstract available

FERDINANDUS J, Fendler WP, Farolfi A, Washington S, et al
PSMA PET validates higher rates of metastatic disease for European Association of Urology Biochemical Recurrence Risk Groups: an international multicenter study.
J Nucl Med. 2021 Oct 7. pii: jnumed.121.262821. doi: 10.2967/jnumed.121.262821.
PubMed Abstract available

KESSLER L, Ferdinandus J, Hirmas N, Zarrad F, et al
Pitfalls and common findings in (68)Ga-FAPI-PET - A pictorial analysis.
J Nucl Med. 2021 Oct 7. pii: jnumed.121.262808. doi: 10.2967/jnumed.121.262808.
PubMed Abstract available

MAHAJAN S, Barker CA, Mauguen A, D'Angelo SP, et al
(18)F-FDG PET/CT for post-treatment surveillance imaging of patients with stage III Merkel cell carcinoma.
J Nucl Med. 2021 Oct 7. pii: jnumed.121.262882. doi: 10.2967/jnumed.121.262882.
PubMed Abstract available

BARATTO L, Hawk KE, States L, Qi J, et al
PET/MRI Improves Management of Children with Cancer.
J Nucl Med. 2021;62:1334-1340.
PubMed Abstract available

JOHNSON BJ, Van Abel KM, Ma DJ, Johnson DR, et al
(18)F-FDG-Avid Axillary Lymph Nodes After COVID-19 Vaccination.
J Nucl Med. 2021;62:1483-1484.
PubMed

September 2021

TAHERPOUR J, Jaber M, Voges B, Apostolova I, et al
Predicting the outcome of epilepsy surgery by covariance pattern analysis of ictal perfusion SPECT.
J Nucl Med. 2021 Sep 30. pii: jnumed.121.262702. doi: 10.2967/jnumed.121.262702.
PubMed Abstract available

XU M, Zhang P, Ding J, Chen J, et al
Albumin Binder-Conjugated Fibroblast Activation Protein Inhibitor Radiopharmaceuticals for Cancer Therapy.
J Nucl Med. 2021 Sep 30. pii: jnumed.121.262533. doi: 10.2967/jnumed.121.262533.
PubMed Abstract available

PALESTRO C, Clark A, Grady E, Heiba S, et al
Appropriate Use Criteria for the Use of Nuclear Medicine in Musculoskeletal Infection Imaging.
J Nucl Med. 2021 Sep 30. pii: jnumed.121.262579. doi: 10.2967/jnumed.121.262579.
PubMed

CROMPTON J, Armstrong WR, Eckardt MA, Seyedroudbari A, et al
(18)F-FLT PET/CT as a prognostic imaging biomarker of disease specific survival in patients with primary soft tissue sarcoma.
J Nucl Med. 2021 Sep 30. pii: jnumed.121.262502. doi: 10.2967/jnumed.121.262502.
PubMed Abstract available

JADVAR H, Calais J, Fanti S, Feng F, et al
Appropriate Use Criteria for Prostate-Specific Membrane Antigen PET Imaging.
J Nucl Med. 2021 Sep 30. pii: jnumed.121.263262. doi: 10.2967/jnumed.121.263262.
PubMed

GU B, Xu X, Zhang J, Ou X, et al
The Added Value of (68)Ga-FAPI-04 PET/CT in Patients with Head and Neck Cancer of Unknown Primary with (18)F-FDG Negative Findings.
J Nucl Med. 2021 Sep 30. pii: jnumed.121.262790. doi: 10.2967/jnumed.121.262790.
PubMed Abstract available

HU Y, Liu G, Yu H, Wang Y, et al
Feasibility of ultra-low (18)F-FDG activity acquisitions using total-body PET/CT.
J Nucl Med. 2021 Sep 30. pii: jnumed.121.262038. doi: 10.2967/jnumed.121.262038.
PubMed Abstract available

ZHAO L, Niu B, Fang J, Pang Y, et al
Synthesis, preclinical evaluation, and a pilot clinical PET imaging study of (68)Ga-labeled FAPI dimer.
J Nucl Med. 2021 Sep 23. pii: jnumed.121.263016. doi: 10.2967/jnumed.121.263016.
PubMed Abstract available

WEBER M, Schmitz J, Maric I, Pabst KM, et al
Diagnostic performance of [(124)I]m-iodobenzylguanidine PET/CT in patients with pheochromocytoma.
J Nucl Med. 2021 Sep 23. pii: jnumed.121.262797. doi: 10.2967/jnumed.121.262797.
PubMed Abstract available

SONG H, Iagaru A, Rowe SP
(18)F DCFPyL PET Acquisition, Interpretation and Reporting: Suggestions Post Food and Drug Administration Approval.
J Nucl Med. 2021 Sep 16. pii: jnumed.121.262989. doi: 10.2967/jnumed.121.262989.
PubMed Abstract available

NIENHUIS PH, Antunes IF, Glaudemans AWJM, Jalving M, et al
(18)F-BMS986192 PET imaging of PD-L1 in metastatic melanoma patients with brain metastases treated with immune checkpoint inhibitors. A pilot study.
J Nucl Med. 2021 Sep 9. pii: jnumed.121.262368. doi: 10.2967/jnumed.121.262368.
PubMed Abstract available

ZANOVELLO M, Soraru G, Campi C, Anglani M, et al
Brainstem glucose hypermetabolism in ALS/FTD and shorten survival: a (18)F-FDG PET/MR study.
J Nucl Med. 2021 Sep 9. pii: jnumed.121.262232. doi: 10.2967/jnumed.121.262232.
PubMed Abstract available

MHLANGA J, Haq A, Derenoncourt P, Bhandiwad A, et al
(18)F-FDG Positron Emission Tomography in Myocardial Viability Assessment: A Practical and Time Efficient Protocol.
J Nucl Med. 2021 Sep 9. pii: jnumed.121.262432. doi: 10.2967/jnumed.121.262432.
PubMed Abstract available

LAFFON E, Marthan R
On Semi-quantitative Methods for Assessing Vascular (18)FDG-PET Activity in Large-Vessels Vasculitis.
J Nucl Med. 2021 Sep 2. pii: jnumed.121.263060. doi: 10.2967/jnumed.121.263060.
PubMed

FOURQUET A, Rosenberg A, Mena E, Shih JJ, et al
A comparison of (18)F-DCFPyL, (18)F-NaF and (18)F-FDG PET/CT in a prospective cohort of men with metastatic prostate cancer.
J Nucl Med. 2021 Sep 2. pii: jnumed.121.262371. doi: 10.2967/jnumed.121.262371.
PubMed Abstract available

CARRASQUILLO JA, Chen CC, Jha A, Pacak K, et al
Systemic Radiopharmaceutical Therapy of Pheochromocytoma and Paraganglioma.
J Nucl Med. 2021;62:1192-1199.
PubMed Abstract available

August 2021

SEIFERT R, Sandach P, Kersting D, Fendler WP, et al
Repeatability of (68)Ga-PSMA-HBED-CC PET/CT-derived total molecular tumor volume.
J Nucl Med. 2021 Aug 26. pii: jnumed.121.262528. doi: 10.2967/jnumed.121.262528.
PubMed Abstract available

BAG AK, Wing MN, Sabin ND, Hwang SN, et al
[(11)C]-Methionine PET for Identification of Pediatric High-Grade Glioma Recurrence.
J Nucl Med. 2021 Aug 26. pii: jnumed.120.261891. doi: 10.2967/jnumed.120.261891.
PubMed Abstract available

LO AC, James LP, Prica A, Raymakers A, et al
Positron-emission tomography-based staging is cost-effective in early-stage follicular lymphoma.
J Nucl Med. 2021 Aug 19. pii: jnumed.121.262324. doi: 10.2967/jnumed.121.262324.
PubMed Abstract available

FARWELL MD, Gamache RF, Babazada H, Hellmann MD, et al
CD8-targeted PET Imaging of Tumor Infiltrating T cells in Patients with Cancer: A Phase I First-in-Human Study of (89)Zr-Df-IAB22M2C, a Radiolabeled anti-CD8 Minibody.
J Nucl Med. 2021 Aug 19. pii: jnumed.121.262485. doi: 10.2967/jnumed.121.262485.
PubMed Abstract available

PARIHAR AS, Schmidt LR, Dehdashti F, Wahl RL, et al
Detection of additional primary neoplasms on (18)F-Fluciclovine PET/CT in patients with primary prostate cancer.
J Nucl Med. 2021 Aug 19. pii: jnumed.121.262647. doi: 10.2967/jnumed.121.262647.
PubMed Abstract available

PAQUETTE M, Espinosa-Bentancourt E, Lavallee E, Phoenix S, et al
(18)F-4FMFES and (18)F-FDG PET/CT in ER+ endometrial carcinomas: preliminary report.
J Nucl Med. 2021 Aug 19. pii: jnumed.121.262617. doi: 10.2967/jnumed.121.262617.
PubMed Abstract available

MATHEY C, Keyzer C, Blocklet D, Van Simaeys G, et al
(18)F-fluorocholine PET/CT is more sensitive than (11)C-methionine PET/CT for the localization of hyperfunctioning parathyroid tissue in primary hyperparathyroidism.
J Nucl Med. 2021 Aug 19. pii: jnumed.121.262395. doi: 10.2967/jnumed.121.262395.
PubMed Abstract available

SMIT J, Borm FJ, Niemeijer AN, Huisman MC, et al
PD-L1 PET/CT imaging with radiolabeled durvalumab in patients with advanced stage non-small cell lung cancer.
J Nucl Med. 2021 Aug 12. pii: jnumed.121.262473. doi: 10.2967/jnumed.121.262473.
PubMed Abstract available

HOFMAN MS
Bringing VISION to Nuclear Medicine: accelerating evidence and changing paradigms with theranostics.
J Nucl Med. 2021 Aug 12. pii: jnumed.121.262890. doi: 10.2967/jnumed.121.262890.
PubMed

LANGBEIN T, Wurzer A, Gafita A, Robertson A, et al
The Influence of Specific Activity on the Biodistribution of (18)F-rhPSMA-7.3: A Retrospective Analysis of Clinical Positron Emission Tomography Data.
J Nucl Med. 2021 Aug 12. pii: jnumed.121.262471. doi: 10.2967/jnumed.121.262471.
PubMed Abstract available

LU P, Benabdallah N, Jiang W, Simons BW, et al
Blind Image Restoration Enhances Digital Autoradiographic Imaging of Radiopharmaceutical Tissue Distribution.
J Nucl Med. 2021 Aug 12. pii: jnumed.121.262270. doi: 10.2967/jnumed.121.262270.
PubMed Abstract available

NAGANAWA M, Nabulsi NB, Matuskey D, Henry S, et al
Imaging pituitary vasopressin 1B receptor in humans with the novel PET radiotracer (11)C-TASP699.
J Nucl Med. 2021 Aug 12. pii: jnumed.121.262430. doi: 10.2967/jnumed.121.262430.
PubMed Abstract available

FENG T, Wu Y, Zhao Y, Xu T, et al
Whole-body Parametric Imaging of FDG PET using uEXPLORER with Reduced Scan Time.
J Nucl Med. 2021 Aug 12. pii: jnumed.120.261651. doi: 10.2967/jnumed.120.261651.
PubMed Abstract available

STABIN MG, Wendt RE 3rd, Flux GD
RADAR Guide: Standard Methods for Calculating Radiation Doses for Radiopharmaceuticals Part 1. Collection of Data for Radiopharmaceutical Dosimetry.
J Nucl Med. 2021 Aug 5. pii: jnumed.120.259200. doi: 10.2967/jnumed.120.259200.
PubMed Abstract available

STABIN MG, Wendt RE 3rd, Flux GD
RADAR Guide: Standard Methods for Calculating Radiation Doses for Radiopharmaceuticals Part 2. Data Analysis and Dosimetry.
J Nucl Med. 2021 Aug 5. pii: jnumed.121.262034. doi: 10.2967/jnumed.121.262034.
PubMed Abstract available

BRENDLE C, Maier C, Bender B, Schittenhelm J, et al
Impact of (18)F-FET PET/MR on clinical management of brain tumor patients.
J Nucl Med. 2021 Aug 5. pii: jnumed.121.262051. doi: 10.2967/jnumed.121.262051.
PubMed Abstract available

IAGARU A
2021 SNMMI Highlights Lecture: General Nuclear Medicine.
J Nucl Med. 2021;62:12N-17N.
PubMed

FDA Approves (18)F-DCFPyL PET Agent in Prostate Cancer.
J Nucl Med. 2021;62:11N.
PubMed

CZERNIN J, Calais J
(177)Lu-PSMA617 and the VISION Trial: One of the Greatest Success Stories in the History of Nuclear Medicine.
J Nucl Med. 2021;62:1025-1026.
PubMed

July 2021

DIETLEIN F, Kobe C, Munoz Vazquez S, Fischer T, et al
An (89)Zr-labeled PSMA tracer for PET/CT imaging of prostate cancer patients.
J Nucl Med. 2021 Jul 29. pii: jnumed.121.262290. doi: 10.2967/jnumed.121.262290.
PubMed Abstract available

DONG L, Su Y, Zhu Y, Markowski MC, et al
The European Association of Urology Biochemical Recurrence Risk Groups Predict Findings on PSMA PET in Patients with Biochemically Recurrent Prostate Cancer after Radical Prostatectomy.
J Nucl Med. 2021 Jul 29. pii: jnumed.121.262411. doi: 10.2967/jnumed.121.262411.
PubMed Abstract available

ABGHARI-GERST M, Armstrong WR, Nguyen K, Calais J, et al
A comprehensive assessment of (68)Ga-PSMA-11 PET in biochemically recurrent prostate cancer: Results from a prospective multi-center study in 2005 patients.
J Nucl Med. 2021 Jul 29. pii: jnumed.121.262412. doi: 10.2967/jnumed.121.262412.
PubMed Abstract available

ZHOU X, Jiang J, Yang X, Liu T, et al
First-in-human evaluation of a PD-L1-binding peptide radiotracer in non-small cell lung cancer patients with PET.
J Nucl Med. 2021 Jul 29. pii: jnumed.121.262045. doi: 10.2967/jnumed.121.262045.
PubMed Abstract available

CATANA C, Laforest R, An H, Boada F, et al
A Path to Qualification of PET/MR Scanners for Multicenter Brain Imaging Studies: Evaluation of MR-based Attenuation Correction Methods Using a Patient Phantom.
J Nucl Med. 2021 Jul 22. pii: jnumed.120.261881. doi: 10.2967/jnumed.120.261881.
PubMed Abstract available

PRENOSIL GA, Sari H, Furstner M, Afshar-Oromieh A, et al
Performance Characteristics of the Biograph Vision Quadra PET/CT system with long axial field of view using the NEMA NU 2-2018 Standard.
J Nucl Med. 2021 Jul 22. pii: jnumed.121.261972. doi: 10.2967/jnumed.121.261972.
PubMed Abstract available

OREVI M, Chicheportiche A, Ben-Haim S
Lessons learned from post-COVID-19 vaccination PET/CT studies.
J Nucl Med. 2021 Jul 22. pii: jnumed.121.262348. doi: 10.2967/jnumed.121.262348.
PubMed Abstract available

GANS D, Braet P, Ahmadi Bidakhvidi N, Deroose CM, et al
(18)F-FDG PET-CT sheds a Light on a Case of Hyponatremia.
J Nucl Med. 2021 Jul 22. pii: jnumed.121.262369. doi: 10.2967/jnumed.121.262369.
PubMed Abstract available

ROHRICH M, Leitz D, Glatting FM, Wefers AK, et al
Fibroblast Activation Protein specific PET/CT imaging in fibrotic interstitial lung diseases and lung cancer: a translational exploratory study.
J Nucl Med. 2021 Jul 16. pii: jnumed.121.261925. doi: 10.2967/jnumed.121.261925.
PubMed Abstract available

SANCHEZ-CATASUS C, Bohnen NI, D'Cruz N, Muller M, et al
Striatal acetylcholine-dopamine imbalance in Parkinson's disease: in vivo neuroimaging study with dual-tracer PET and dopaminergic PET-informed correlational tractography.
J Nucl Med. 2021 Jul 16. pii: jnumed.121.261939. doi: 10.2967/jnumed.121.261939.
PubMed Abstract available

IMPERIALE A, Boursier C, Sahakian N, Ouvrard E, et al
Values of (68)Ga-DOTATOC and Carbidopa-assisted (18)F-DOPA PET/CT for insulinoma localization.
J Nucl Med. 2021 Jul 16. pii: jnumed.121.262401. doi: 10.2967/jnumed.121.262401.
PubMed Abstract available

THORNTON A, Fraioli F, Wan S, Garthwaite HS, et al
Evolution of (18)F-FDG-PET/CT findings in patients following COVID-19 pneumonia: An Initial Investigation.
J Nucl Med. 2021 Jul 16. pii: jnumed.121.262296. doi: 10.2967/jnumed.121.262296.
PubMed Abstract available

BENZ MR, Armstrong WR, Ceci F, Polverari G, et al
(18)F-FDG PET/CT imaging biomarkers for early and late evaluation of response to first-line chemotherapy in patients with pancreatic ductal adenocarcinoma.
J Nucl Med. 2021 Jul 16. pii: jnumed.121.261952. doi: 10.2967/jnumed.121.261952.
PubMed Abstract available

NIEMEIJER AN, Oprea Lager DE, Huisman MC, Hoekstra OS, et al
First-in-human study of (89)Zr-pembrolizumab PET/CT in patients with advanced stage non-small-cell lung cancer.
J Nucl Med. 2021 Jul 16. pii: jnumed.121.261926. doi: 10.2967/jnumed.121.261926.
PubMed Abstract available

READER AJ, Schramm G
AI for PET image reconstruction.
J Nucl Med. 2021 Jul 8. pii: jnumed.121.262303. doi: 10.2967/jnumed.121.262303.
PubMed

IM C, Kim H, Zaheer J, Kim JY, et al
PET tracing of biodistribution for orally administered (64)Cu-labeled polystyrene in mice.
J Nucl Med. 2021 Jul 2. pii: jnumed.120.256982. doi: 10.2967/jnumed.120.256982.
PubMed Abstract available

BOSS M, Rottenburger C, Brenner W, Blankenstein O, et al
(68)Ga-NODAGA-exendin-4 PET improves the detection of focal congenital hyperinsulinism.
J Nucl Med. 2021 Jul 2. pii: jnumed.121.262327. doi: 10.2967/jnumed.121.262327.
PubMed Abstract available

STATES LJ, Davis JC, Hamel SM, Becker SA, et al
(18)F-6-Fluoro-l-Dopa PET/CT Imaging of Congenital Hyperinsulinism.
J Nucl Med. 2021;62.
PubMed Abstract available

WAHL R
Nuclear Medicine Innovations: Providing Access for All.
J Nucl Med. 2021;62:16N.
PubMed

MARZELLA L, Czernin J, Hope T
Perspectives on Radiopharmaceutical Agents from the FDA: A Conversation between Lou Marzella, Johannes Czernin, and Thomas Hope.
J Nucl Med. 2021;62:881-883.
PubMed

BLAZHENETS G, Schroeter N, Bormann T, Thurow J, et al
Slow but Evident Recovery from Neocortical Dysfunction and Cognitive Impairment in a Series of Chronic COVID-19 Patients.
J Nucl Med. 2021;62:910-915.
PubMed Abstract available

June 2021

BARCA C, Kiliaan AJ, Foray C, Wachsmuth L, et al
A longitudinal PET/MR imaging study of colony stimulating factor-1 receptor-mediated microglia depletion in experimental stroke.
J Nucl Med. 2021 Jun 24. pii: jnumed.121.262279. doi: 10.2967/jnumed.121.262279.
PubMed Abstract available

CZERNIN J, Calais J
(177)Lu-PSMA617 and the VISION Trial: One of the Greatest Success Stories in the History of Nuclear Medicine.
J Nucl Med. 2021 Jun 24. pii: jnumed.121.262710. doi: 10.2967/jnumed.121.262710.
PubMed

MEIER SR, Sehlin D, Roshanbin S, Lim Falk V, et al
(11)C-PIB and (124)I-antibody PET provide differing estimates of brain amyloid-beta after therapeutic intervention.
J Nucl Med. 2021 Jun 4. pii: jnumed.121.262083. doi: 10.2967/jnumed.121.262083.
PubMed Abstract available

WAKFIE-CORIEH CG, Ferrando-Castagnetto F, Blanes Garcia AM, Garcia-Esquinas MG, et al
Incidental findings suggestive of COVID-19 pneumonia in oncological patients undergoing 18F-FDG PET/CT studies: association between metabolic and structural lung changes.
J Nucl Med. 2021 Jun 4. pii: jnumed.121.261915. doi: 10.2967/jnumed.121.261915.
PubMed Abstract available

ZHANG X, Landgraf L, Bailis N, Unger M, et al
Image-guided High-Intensity Focused Ultrasound, A Novel Application for Interventional Nuclear Medicine?
J Nucl Med. 2021 Jun 4. pii: jnumed.120.256230. doi: 10.2967/jnumed.120.256230.
PubMed Abstract available

DASHORA HR, Rosenblum JS, Quinn KA, Alessi H, et al
Comparing Semi-quantitative and Qualitative Methods of Vascular FDG-PET Activity Measurement in Large-Vessel Vasculitis.
J Nucl Med. 2021 Jun 4. pii: jnumed.121.262326. doi: 10.2967/jnumed.121.262326.
PubMed Abstract available

ORELLANA P, Mut F, Estrada E, Lette MM, et al
Status of Nuclear Medicine in Latin America and the Caribbean: IAEA Analysis of Development in the Past 6 Years.
J Nucl Med. 2021;62:23N-29N.
PubMed

ALLIS J, Mankoff D
Industry Perspective on the Changing Nuclear Medicine Landscape: A Conversation Between Jonathan Allis and David Mankoff.
J Nucl Med. 2021;62:749-751.
PubMed

GAN HK, Burge M, Solomon B, Lee ST, et al
A Phase 1 and Biodistribution Study of ABT-806i, an (111)In-Radiolabeled Conjugate of the Tumor-Specific Anti-EGFR Antibody ABT-806.
J Nucl Med. 2021;62:787-794.
PubMed Abstract available

EBBERS SC, Barentsz MW, de Keizer B, Krijger GC, et al
A Rapid and Safe Infusion Protocol for (177)Lu Peptide Receptor Radionuclide Therapy.
J Nucl Med. 2021;62:816-822.
PubMed Abstract available

ERIKSSON O, Velikyan I, Haack T, Bossart M, et al
Imaging of the Glucagon Receptor in Subjects with Type 2 Diabetes.
J Nucl Med. 2021;62:833-838.
PubMed Abstract available

May 2021

GAFITA A, Wang H, Robertson A, Armstrong WR, et al
Tumor sink effect in (68)Ga-PSMA-11 PET: Myth or Reality?
J Nucl Med. 2021 May 28. pii: jnumed.121.261906. doi: 10.2967/jnumed.121.261906.
PubMed Abstract available

RAMAN F, Fang YD, Grandhi S, Murchison CF, et al
Dynamic Amyloid PET: Relationships to Flortaucipir Tau PET Measures.
J Nucl Med. 2021 May 28. pii: jnumed.120.254490. doi: 10.2967/jnumed.120.254490.
PubMed Abstract available

JIN X, Wei M, Wang S, Wang G, et al
Detecting fibroblast activation proteins in lymphoma using (68)Ga-FAPI PET/CT.
J Nucl Med. 2021 May 28. pii: jnumed.121.262134. doi: 10.2967/jnumed.121.262134.
PubMed Abstract available

JACENE HA, Liu M, Cheng SC, Abbott A, et al
Imaging Androgen Receptors in Breast Cancer with (18)F-fluoro-5alpha-dihydrotestosterone-PET: A Pilot Study.
J Nucl Med. 2021 May 28. pii: jnumed.121.262068. doi: 10.2967/jnumed.121.262068.
PubMed Abstract available

SEBAN RD, Champion L, Muneer I, Synn S, et al
Potential theranostic role of bone marrow glucose metabolism on baseline [18F]-FDG PET/CT in metastatic melanoma.
J Nucl Med. 2021 May 28. pii: jnumed.121.262361. doi: 10.2967/jnumed.121.262361.
PubMed

KRAUS S, Dierks A, Rasche L, Kertels O, et al
(68)Ga-Pentixafor-PET/CT imaging represents a novel approach to detect chemokine receptor CXCR4 expression in myeloproliferative neoplasms.
J Nucl Med. 2021 May 28. pii: jnumed.121.262206. doi: 10.2967/jnumed.121.262206.
PubMed Abstract available

MUNOZ C, Ellis S, Nekolla SG, Kunze KP, et al
MR-guided motion-corrected PET image reconstruction for cardiac PET-MR.
J Nucl Med. 2021 May 28. pii: jnumed.120.254235. doi: 10.2967/jnumed.120.254235.
PubMed Abstract available

BIECHELE G, Sebastian Monasor L, Wind K, Blume T, et al
Glitter in the Darkness? Non-fibrillar beta-amyloid Plaque Components Significantly Impact the beta-amyloid PET Signal in Mouse Models of Alzheimer's Disease.
J Nucl Med. 2021 May 20. pii: jnumed.120.261858. doi: 10.2967/jnumed.120.261858.
PubMed Abstract available

ZARAGORI T, Oster J, Roch V, Hossu G, et al
(18)F-FDOPA PET for the non-invasive prediction of glioma molecular parameters: a radiomics study.
J Nucl Med. 2021 May 20. pii: jnumed.120.261545. doi: 10.2967/jnumed.120.261545.
PubMed Abstract available

GUBERINA M, Poettgen C, Metzenmacher M, Wiesweg M, et al
PROGNOSTIC VALUE OF POST-INDUCTION CHEMOTHERAPY VOLUMETRIC PET/CT PARAMETERS FOR STAGE IIIA/B NON-SMALL CELL LUNG CANCER PATIENTS RECEIVING DEFINITIVE CHEMORADIOTHERAPY.
J Nucl Med. 2021 May 20. pii: jnumed.120.260646. doi: 10.2967/jnumed.120.260646.
PubMed Abstract available

MORAWITZ J, Bruckmann NM, Dietzel F, Ullrich T, et al
Determining the axillary nodal status with four current imaging modalities including (18)F-FDG PET/MRI in newly diagnosed breast cancer: A comparative study using histopathology as reference standard.
J Nucl Med. 2021 May 20. pii: jnumed.121.262009. doi: 10.2967/jnumed.121.262009.
PubMed Abstract available

COLLET S, Guillamo JS, Berro DH, Chakhoyan A, et al
Simultaneous mapping of vasculature, hypoxia and proliferation using DSC-MRI, (18)F-FMISO PET, and (18)F-FLT PET in relation to contrast enhancement in newly diagnosed glioblastoma.
J Nucl Med. 2021 May 20. pii: jnumed.120.249524. doi: 10.2967/jnumed.120.249524.
PubMed Abstract available

BARBATO F, Fendler WP, Rauscher I, Herrmann K, et al
PSMA-PET for the assessment of metastatic hormone-sensitive prostate cancer volume of disease.
J Nucl Med. 2021 May 14. pii: jnumed.121.262120. doi: 10.2967/jnumed.121.262120.
PubMed Abstract available

EL-ATOUM B, Ebert M, Bucher B, Afify Z, et al
Is (18)F-FDG PET/CT effective in identifying true residual disease after treatment of pediatric PTLD?
J Nucl Med. 2021 May 14. pii: jnumed.121.262414. doi: 10.2967/jnumed.121.262414.
PubMed

BOERS J, Loudini N, Brunsch CL, Koza SA, et al
Value of (18)F-FES-PET to solve clinical dilemmas in breast cancer patients: a retrospective study.
J Nucl Med. 2021 May 14. pii: jnumed.120.256826. doi: 10.2967/jnumed.120.256826.
PubMed Abstract available

HENDERSON TA, DeBruin S, Briandet P
(18)F-FDG PET National Coverage Determination for Infection/Inflammation Retired.
J Nucl Med. 2021;62:18N-22N.
PubMed

WAHL RL, Ahuja S, Clarke B
Current Landscape of Radiopharmaceutical Therapies: SNMMI Therapy Task Force Survey.
J Nucl Med. 2021;62:11N-16N.
PubMed

Challenges and Promise for Nuclear Medicine in Africa: A Conversation Between Mike Sathekge and Johannes Czernin.
J Nucl Med. 2021;62:593-595.
PubMed

YOSHINAGA K, Abe T, Okamoto S, Uchiyama Y, et al
Effects of Repeated (131)I-Meta-Iodobenzylguanidine Radiotherapy on Tumor Size and Tumor Metabolic Activity in Patients with Metastatic Neuroendocrine Tumors.
J Nucl Med. 2021;62:685-694.
PubMed Abstract available

NAZERI A, Crandall JP, Fraum TJ, Wahl RL, et al
Repeatability of Radiomic Features of Brown Adipose Tissue.
J Nucl Med. 2021;62:700-706.
PubMed Abstract available

FENG T, Zhao Y, Shi H, Li H, et al
Total-Body Quantitative Parametric Imaging of Early Kinetics of (18)F-FDG.
J Nucl Med. 2021;62:738-744.
PubMed Abstract available

SCHAEFER WM, Knollmann D, Meyer PT
Q/V-SPECT CT in times of COVID-19: Changing the order to improve safety without sacrificing accuracy.
J Nucl Med. 2021 May 7. pii: jnumed.120.261263. doi: 10.2967/jnumed.120.261263.
PubMed

April 2021

KESSLER L, Ferdinandus J, Hirmas N, Bauer S, et al
Ga-68-FAPI as diagnostic tool in sarcoma: Data from the FAPI-PET prospective observational trial.
J Nucl Med. 2021 Apr 30. pii: jnumed.121.262096. doi: 10.2967/jnumed.121.262096.
PubMed Abstract available

COHEN AS, Grudzinski J, Smith GT, Peterson TE, et al
First-in-human PET imaging and estimated radiation dosimetry of L-[5-(11)C]-glutamine in patients with metastatic colorectal cancer.
J Nucl Med. 2021 Apr 30. pii: jnumed.120.261594. doi: 10.2967/jnumed.120.261594.
PubMed Abstract available

CHENG JL, Dibble EH, Baird GL, Gordon LL, et al
Diversity, Equity, and Inclusion in Academic Nuclear Medicine: National Survey of Nuclear Medicine Residency Program Directors.
J Nucl Med. 2021 Apr 23. pii: jnumed.120.260711. doi: 10.2967/jnumed.120.260711.
PubMed Abstract available

KWIECINSKI J, Tzolos E, Meah M, Cadet S, et al
Machine-learning with (18)F-sodium fluoride PET and quantitative plaque analysis on CT angiography for the future risk of myocardial infarction.
J Nucl Med. 2021 Apr 23. pii: jnumed.121.262283. doi: 10.2967/jnumed.121.262283.
PubMed Abstract available

FENDLER WP, Herrmann K, Eiber M
Nuclear Medicine beyond VISION.
J Nucl Med. 2021 Apr 23. pii: jnumed.121.262441. doi: 10.2967/jnumed.121.262441.
PubMed

CHEN R, Wang Y, Zhu Y, Shi Y, et al
The added value of (18)F-FDG PET/CT compared to (68)Ga-PSMA PET/CT in patients with castration-resistant prostate cancer.
J Nucl Med. 2021 Apr 23. pii: jnumed.121.262250. doi: 10.2967/jnumed.121.262250.
PubMed Abstract available

EIFER M, Tau N, Alhoubani Y, Kanana N, et al
Covid-19 mRNA Vaccination: Age and Immune Status and its Association with Axillary Lymph Node PET/CT Uptake.
J Nucl Med. 2021 Apr 23. pii: jnumed.121.262194. doi: 10.2967/jnumed.121.262194.
PubMed Abstract available

GHZALLY Y, Imanli H, Smith M, Mahat J, et al
Metabolic Scar Assessment with (18)F-FDG -PET: Correlation to Ischemic VT Substrate and Successful Ablation Sites.
J Nucl Med. 2021 Apr 23. pii: jnumed.120.246413. doi: 10.2967/jnumed.120.246413.
PubMed Abstract available

GOGOLA A, Minhas DS, Villemagne VL, Cohen AD, et al
Direct comparison of the tau PET tracers [(18)F]flortaucipir and [(18)F]MK-6240 in human subjects.
J Nucl Med. 2021 Apr 16. pii: jnumed.120.254961. doi: 10.2967/jnumed.120.254961.
PubMed Abstract available

YOUNG AJ, Pantel AR, Viswanath V, Dominguez TL, et al
Kinetic and static analysis of poly-(adenosine diphosphate-ribose) polymerase-1 (PARP-1) targeted (18)F-FluorThanatrace ((18)F-FTT) PET images of ovarian cancer.
J Nucl Med. 2021 Apr 16. pii: jnumed.121.261894. doi: 10.2967/jnumed.121.261894.
PubMed Abstract available

QIN C, Shao F, Gai Y, Liu Q, et al
(68)Ga-DOTA-FAPI-04 PET/MR in the evaluation of gastric carcinomas: comparison with (18)F-FDG PET/CT.
J Nucl Med. 2021 Apr 16. pii: jnumed.120.258467. doi: 10.2967/jnumed.120.258467.
PubMed Abstract available

LUKEY PT, Wilson FJ
Quantification of the alphavbeta6 Integrin by PET/CT Imaging in the Lungs of Patients after SARS-CoV2 Infection and Comparison to Fibrotic Lungs.
J Nucl Med. 2021 Apr 9. pii: jnumed.121.262342. doi: 10.2967/jnumed.121.262342.
PubMed

GUGLIELMETTI C, Levi J, Huynh TL, Tiret B, et al
Longitudinal imaging of T-cells and inflammatory demyelination in a preclinical model of multiple sclerosis using (18)F-FAraG PET and MRI.
J Nucl Med. 2021 Apr 9. pii: jnumed.120.259325. doi: 10.2967/jnumed.120.259325.
PubMed Abstract available

KUO HT, Lin KS, Zhang Z, Uribe CF, et al
(177)Lu-Labeled Albumin-Binder-Conjugated PSMA-Targeting Agents with Extremely High Tumor Uptake and Enhanced Tumor-to-Kidney Absorbed Dose Ratio.
J Nucl Med. 2021;62:521-527.
PubMed Abstract available

March 2021

BATEMAN TM, Heller GV, Beanlands R, Calnon DA, et al
Practical guide for interpreting and reporting cardiac PET measurements of myocardial blood flow: an Information Statement from the American Society of Nuclear Cardiology, and the Society of Nuclear Medicine and Molecular Imaging.
J Nucl Med. 2021 Mar 31. pii: jnumed.121.261989. doi: 10.2967/jnumed.121.261989.
PubMed

BAKKER IL, Froberg AC, Busstra MB, Verzijlbergen JF, et al
GRPr antagonist (68)Ga-SB3 PET/CT-imaging of primary prostate cancer in therapy-naive patients.
J Nucl Med. 2021 Mar 31. pii: jnumed.120.258814. doi: 10.2967/jnumed.120.258814.
PubMed Abstract available

MICHALSKI K, Klein C, Brueggemann T, Meyer PT, et al
Assessing Response to [(177)Lu]PSMA Radioligand Therapy using modified PSMA PET Progression Criteria.
J Nucl Med. 2021 Mar 31. pii: jnumed.120.260836. doi: 10.2967/jnumed.120.260836.
PubMed Abstract available

VEAL M, Dias G, Kersemans V, Sneddon D, et al
A Model System to Explore the Detection Limits of Antibody-Based Immuno-SPECT Imaging of Exclusively Intranuclear Epitopes.
J Nucl Med. 2021 Mar 31. pii: jnumed.120.251173. doi: 10.2967/jnumed.120.251173.
PubMed Abstract available

IMPERIALE A, Meuter L, Pacak K, Taieb D, et al
Imaging of small intestine neuroendocrine neoplasms: Is SSTR PET the holy grail?
J Nucl Med. 2021 Mar 26. pii: jnumed.121.262140. doi: 10.2967/jnumed.121.262140.
PubMed

BUVAT I, Orlhac F
The T.R.U.E. checklist for identifying impactful AI-based findings in nuclear medicine: is it True? Is it Reproducible? Is it Useful? Is it Explainable?
J Nucl Med. 2021 Mar 26. pii: jnumed.120.261586. doi: 10.2967/jnumed.120.261586.
PubMed

OZUTEMIZ C, Koksel Y, Froelich JW, Rubin N, et al
COMPARISON OF THE EFFECT OF THREE DIFFERENT DIETARY MODIFICATIONS ON MYOCARDIAL SUPPRESSION IN (18)F-FDG PET/CT EVALUATION OF PATIENTS FOR SUSPECTED CARDIAC SARCOIDOSIS.
J Nucl Med. 2021 Mar 26. pii: jnumed.121.261981. doi: 10.2967/jnumed.121.261981.
PubMed Abstract available

PENG S, Tang C, Schindlbeck K, Rydzinski Y, et al
Dynamic (18)F-FPCIT PET: Quantification of Parkinson's disease metabolic networks and nigrostriatal dopaminergic dysfunction in a single imaging session.
J Nucl Med. 2021 Mar 19. pii: jnumed.120.257345. doi: 10.2967/jnumed.120.257345.
PubMed Abstract available

AFAQ A, Payne H, Davda R, Hines J, et al
A Phase II, Open-label study to assess safety and management change using (68)Ga-THP PSMA PET/CT in patients with high risk primary prostate cancer or biochemical recurrence after radical treatment: The PRONOUNCED study.
J Nucl Med. 2021 Mar 19. pii: jnumed.120.257527. doi: 10.2967/jnumed.120.257527.
PubMed Abstract available

NARCISO L, Ssali T, Liu L, Biernaski H, et al
A Noninvasive Method for Quantifying Cerebral Metabolic Rate of Oxygen by Hybrid PET/MRI: Validation in a Porcine Model.
J Nucl Med. 2021 Mar 19. pii: jnumed.120.260521. doi: 10.2967/jnumed.120.260521.
PubMed Abstract available

BUCKNOR MD, Hope T
Reply: "Disparities in PET imaging for prostate cancer at a tertiary academic medical center".
J Nucl Med. 2021 Mar 19. pii: jnumed.121.262332. doi: 10.2967/jnumed.121.262332.
PubMed

VELLEMAN T, Kwee TC, Noordzij W, Ongena Y, et al
The new integrated nuclear medicine and radiology residency program in the Netherlands: why do residents choose to subspecialize in nuclear medicine and why not?
J Nucl Med. 2021 Mar 12. pii: jnumed.120.261503. doi: 10.2967/jnumed.120.261503.
PubMed Abstract available

CZERNIN J, Herrmann K
The disappearance act of Nuclear Medicine in the Netherlands: Just a new trick by the great Harry Houdini?
J Nucl Med. 2021 Mar 12. pii: jnumed.121.262190. doi: 10.2967/jnumed.121.262190.
PubMed

FAROLFI A, Calderoni L, Mattana F, Mei R, et al
Current and emerging clinical applications of PSMA-PET diagnostic imaging for prostate cancer.
J Nucl Med. 2021 Mar 12. pii: jnumed.120.257238. doi: 10.2967/jnumed.120.257238.
PubMed Abstract available

MARCHETTI L, Perrucci L, Pellegrino F, Baroni L, et al
Diagnostic contribution of contrast-enhanced CT as compared to unenhanced low-dose CT in PET/CT staging and treatment response assessment of 18FDG-avid lymphomas: a prospective study.
J Nucl Med. 2021 Mar 12. pii: jnumed.120.259242. doi: 10.2967/jnumed.120.259242.
PubMed Abstract available

UPRIMNY C, Bayerschmidt S, Kroiss AS, Fritz J, et al
Early injection of furosemide increases detection rate of local recurrence in prostate cancer patients with biochemical recurrence referred for (68)Ga-PSMA-11 PET/CT.
J Nucl Med. 2021 Mar 12. pii: jnumed.120.261866. doi: 10.2967/jnumed.120.261866.
PubMed Abstract available

RAUSCHER I, Karimzadeh A, Schiller K, Horn T, et al
Detection efficacy of (18)F-rhPSMA-7.3 PET/CT and impact on patient management in patients with biochemical recurrence of prostate cancer after radical prostatectomy and prior to potential salvage treatment.
J Nucl Med. 2021 Mar 12. pii: jnumed.120.260091. doi: 10.2967/jnumed.120.260091.
PubMed Abstract available

ZWEZERIJNEN GJ, Eertink JJ, Burggraaff CN, Wiegers SE, et al
Interobserver agreement in automated metabolic tumor volume measurements of Deauville score 4 and 5 lesions at interim (18)F-FDG PET in DLBCL.
J Nucl Med. 2021 Mar 5. pii: jnumed.120.258673. doi: 10.2967/jnumed.120.258673.
PubMed Abstract available

HOPE TA, Graces C, Calais J, Ehman E, et al
Accuracy of (18)F-fluorocholine PET for the detection of parathyroid adenomas: prospective single center study.
J Nucl Med. 2021 Mar 5. pii: jnumed.120.256735. doi: 10.2967/jnumed.120.256735.
PubMed Abstract available

BARATTO L, Song H, Duan H, Hatami N, et al
PSMA- and GRPR-targeted PET: Results from 50 Patients with Biochemically Recurrent Prostate Cancer.
J Nucl Med. 2021 Mar 5. pii: jnumed.120.259630. doi: 10.2967/jnumed.120.259630.
PubMed Abstract available

WU H, Czernin J
A Conversation Between Hong Wu and Johannes Czernin.
J Nucl Med. 2021;62:293-295.
PubMed

LODGE MA
Phantom Preparation Using a Dilution Technique.
J Nucl Med. 2021;62:303.
PubMed

ALBRECHT J, Exner S, Grotzinger C, Prasad S, et al
Multimodal Imaging of 2-Cycle PRRT with (177)Lu-DOTA-JR11 and (177)Lu-DOTATOC in an Orthotopic Neuroendocrine Xenograft Tumor Mouse Model.
J Nucl Med. 2021;62:393-398.
PubMed Abstract available

BARRINGTON SF, Zwezerijnen BGJC, de Vet HCW, Heymans MW, et al
Automated Segmentation of Baseline Metabolic Total Tumor Burden in Diffuse Large B-Cell Lymphoma: Which Method Is Most Successful? A Study on Behalf of the PETRA Consortium.
J Nucl Med. 2021;62:332-337.
PubMed Abstract available

PEREIRA PMR, Norfleet J, Lewis JS, Escorcia FE, et al
Immuno-PET Detects Changes in Multi-RTK Tumor Cell Expression Levels in Response to Targeted Kinase Inhibition.
J Nucl Med. 2021;62:366-371.
PubMed Abstract available

February 2021

CARLSEN EA, Johnbeck CB, Loft M, Pfeifer A, et al
Semi-automatic tumor delineation for evaluation of (64)Cu-DOTATATE PET/CT in patients with neuroendocrine neoplasms: prognostication based on lowest lesion uptake and total tumor volume.
J Nucl Med. 2021 Feb 26. pii: jnumed.120.258392. doi: 10.2967/jnumed.120.258392.
PubMed Abstract available

LAFFON E, Marthan R
Specific and Non-Specific Uptake in Quantitative (89)Zr-Immuno-PET.
J Nucl Med. 2021 Feb 26. pii: jnumed.121.262065. doi: 10.2967/jnumed.121.262065.
PubMed

YANG J, Shi L, Wang R, Miller EJ, et al
Direct Attenuation Correction Using Deep Learning for Cardiac SPECT: A Feasibility Study.
J Nucl Med. 2021 Feb 26. pii: jnumed.120.256396. doi: 10.2967/jnumed.120.256396.
PubMed Abstract available

DI CARLI MF
Hot Topic, Why will PET be the future of nuclear cardiology?
J Nucl Med. 2021 Feb 19. pii: jnumed.120.254979. doi: 10.2967/jnumed.120.254979.
PubMed

VERHAGEN MV, Menezes LJ, Neriman D, Watson TA, et al
(18)F-FDG PET/MRI for staging and interim response assessment in pediatric and adolescent Hodgkin lymphoma: a prospective study with (18)F-FDG PET/CT as reference standard.
J Nucl Med. 2021 Feb 19. pii: jnumed.120.260059. doi: 10.2967/jnumed.120.260059.
PubMed Abstract available

ZUKOTYNSKI KA, Emmenegger U, Hotte S, Kapoor A, et al
Prospective, Single-Arm Trial Evaluating Changes in Uptake Patterns on Prostate-Specific Membrane Antigen (PSMA)-Targeted (18)F-DCFPyL PET/CT in Patients with Castration-Resistant Prostate Cancer Starting Abiraterone or Enzalutamide.
J Nucl Med. 2021 Feb 19. pii: jnumed.120.259069. doi: 10.2967/jnumed.120.259069.
PubMed Abstract available

CHAN DL, Ulaner GA, Pattison DA, Wyld D, et al
Dual Positron Emission Tomography imaging in bronchial neuroendocrine neoplasms (NENs): The NETPET score as a prognostic biomarker.
J Nucl Med. 2021 Feb 12. pii: jnumed.120.257659. doi: 10.2967/jnumed.120.257659.
PubMed Abstract available

BARRET O, Zhang L, Alagille D, Constantinescu CC, et al
Dopamine D1 Receptor Agonist PET Tracer Development: Assessment in Non-Human Primates.
J Nucl Med. 2021 Feb 12. pii: jnumed.120.256008. doi: 10.2967/jnumed.120.256008.
PubMed Abstract available

ORTEGA C, Wong RK, Schaefferkoetter J, Veit-Haibach P, et al
Quantitative (68)Ga-DOTATATE PET/CT parameters for the prediction of therapy response in patients with progressive metastatic neuroendocrine tumors treated with (177)Lu-DOTATATE.
J Nucl Med. 2021 Feb 12. pii: jnumed.120.256727. doi: 10.2967/jnumed.120.256727.
PubMed Abstract available

DUELL J, Krummenast F, Schirbel A, Klassen P, et al
Improved primary staging of marginal zone lymphoma by addition of CXCR4-directed PET/CT.
J Nucl Med. 2021 Feb 12. pii: jnumed.120.257279. doi: 10.2967/jnumed.120.257279.
PubMed Abstract available

MARIANI G, Tonaccehra M, Grosso M, Fiore E, et al
The Role of Nuclear Medicine in the Clinical Management of Benign Thyroid Disorders. Part 2. Nodular Goiter, Hypothyroidism, and Subacute Thyroiditis.
J Nucl Med. 2021 Feb 12. pii: jnumed.120.251504. doi: 10.2967/jnumed.120.251504.
PubMed Abstract available

ALBERTS I, Huenermund JN, Sachpekidis C, Zacho HD, et al
Combination of forced diuresis with additional late imaging in (68)Ga-PSMA-11 PET/CT - effects on lesion visibility and radiotracer uptake.
J Nucl Med. 2021 Feb 5. pii: jnumed.120.257741. doi: 10.2967/jnumed.120.257741.
PubMed Abstract available

BODET-MILIN C, Faivre-Chauvet A, Carlier T, Ansquer C, et al
Anti-CEA pretargeted Immuno-PET shows higher sensitivity than DOPA-PET/CT to detect relapsing metastatic medullary thyroid carcinoma: Post- hoc analysis of the iPET-MTC study.
J Nucl Med. 2021 Feb 5. pii: jnumed.120.252791. doi: 10.2967/jnumed.120.252791.
PubMed Abstract available

WONDERGEM M, van der Zant FM, Broos WA, Knol RJ, et al
Matched-pair comparison of (18)F-DCFPyL PET/CT and (18)F-PSMA-1007 PET/CT in 240 prostate cancer patients; inter-reader agreement and lesion detection rate of suspected lesions.
J Nucl Med. 2021 Feb 5. pii: jnumed.120.258574. doi: 10.2967/jnumed.120.258574.
PubMed Abstract available

NAKAMOTO R, Zaba LC, Liang T, Reddy SA, et al
Prognostic value of bone marrow metabolism on pretreatment (18)F-FDG PET/CT in patients with metastatic melanoma treated with anti-PD-1 therapy.
J Nucl Med. 2021 Feb 5. pii: jnumed.120.254482. doi: 10.2967/jnumed.120.254482.
PubMed Abstract available

WAHL RL
SNMMI Leadership Update: Advancing Radiopharmaceutical Therapy.
J Nucl Med. 2021;62:20N.
PubMed

FDA Approves First PSMA-Targeted PET Drug.
J Nucl Med. 2021;62:11N.
PubMed

SARTOR O, Hope TA, Calais J, Fendler WP, et al
Oliver Sartor Talks with Thomas A. Hope, Jeremie Calais, and Wolfgang P. Fendler About FDA Approval of PSMA.
J Nucl Med. 2021;62:146-148.
PubMed

CARLUCCI G, Ippisch R, Slavik R, Mishoe A, et al
(68)Ga-PSMA-11 NDA Approval: A Novel and Successful Academic Partnership.
J Nucl Med. 2021;62:149-155.
PubMed Abstract available

ZANOTTI-FREGONARA P, Lammertsma AA, Innis RB
(11)C Dosimetry Scans Should Be Abandoned.
J Nucl Med. 2021;62:158-159.
PubMed

ALTMANN A, Haberkorn U, Siveke J
The Latest Developments in Imaging of Fibroblast Activation Protein.
J Nucl Med. 2021;62:160-167.
PubMed Abstract available

SLOMKA PJ, Moody JB, Miller RJH, Renaud JM, et al
Quantitative clinical nuclear cardiology, part 2: Evolving/emerging applications.
J Nucl Med. 2021;62:168-176.
PubMed Abstract available

AHMED H, Wallimann R, Haider A, Hosseini V, et al
Preclinical Development of (18)F-OF-NB1 for Imaging GluN2B-Containing N-Methyl-d-Aspartate Receptors and Its Utility as a Biomarker for Amyotrophic Lateral Sclerosis.
J Nucl Med. 2021;62:259-265.
PubMed Abstract available

HADDAD J, Latoche JD, Nigam S, Bellavia MC, et al
Molecular Imaging of Very Late Antigen-4 in Acute Lung Injury.
J Nucl Med. 2021;62:280-286.
PubMed Abstract available

January 2021

SCHILHAM MG, Zamecnik P, Prive BM, Israel B, et al
Head-to-head comparison of (68)Ga-prostate-specific membrane antigen PET/CT and ferumoxtran-10 enhanced MRI for the diagnosis of lymph node metastases in prostate cancer patients.
J Nucl Med. 2021 Jan 30. pii: jnumed.120.258541. doi: 10.2967/jnumed.120.258541.
PubMed Abstract available

WHITTINGTON A, Gunn R
TauIQ - A canonical image based algorithm to quantify tau PET scans.
J Nucl Med. 2021 Jan 30. pii: jnumed.120.258962. doi: 10.2967/jnumed.120.258962.
PubMed Abstract available

F ANTUNES I, Dost R, Hoving HD, Waarde AV, et al
Synthesis and evaluation of (18)F-enzalutamide, a new radioligand for PET Imaging of Androgen Receptors: A comparison with 16beta-(18)F-fluoro-5alpha-dihydrotestosterone.
J Nucl Med. 2021 Jan 30. pii: jnumed.120.253641. doi: 10.2967/jnumed.120.253641.
PubMed Abstract available

ROBU S, Richter A, Gosmann D, Seidl C, et al
Synthesis and Preclinical Evaluation of (68)Ga-labeled Adnectin, (68)Ga-BMS-986192 as a PET Agent for Imaging PD-L1 Expression.
J Nucl Med. 2021 Jan 30. pii: jnumed.120.258384. doi: 10.2967/jnumed.120.258384.
PubMed Abstract available

ABIODUN-OJO OA, Jani AB, Akintayo AA, Akin-Akintayo OO, et al
Salvage Radiotherapy Management Decision in Post-prostatectomy Patients with Recurrent Prostate Cancer Based on (18)F-Fluciclovine PET/CT Guidance.
J Nucl Med. 2021 Jan 30. pii: jnumed.120.256784. doi: 10.2967/jnumed.120.256784.
PubMed Abstract available

WEISSINGER M, Taran FA, Gatidis S, Kommoss S, et al
Lymph node staging with a combined protocol of (18)F-FDG PET/MRI and sentinel node SPECT/CT: a prospective study in patients with FIGO I/II cervical carcinoma.
J Nucl Med. 2021 Jan 28. pii: jnumed.120.255919. doi: 10.2967/jnumed.120.255919.
PubMed Abstract available

HIRMAS N, Leyh C, Sraieb M, Barbato F, et al
[(68)Ga]Ga-PSMA-11 PET/CT improves tumor detection and impacts management in patients with hepatocellular carcinoma (HCC).
J Nucl Med. 2021 Jan 28. pii: jnumed.120.257915. doi: 10.2967/jnumed.120.257915.
PubMed Abstract available

KESNER AL
The Evolution of PET/MR is Hindered by our Field's Reluctance to Provide Critical Evaluation.
J Nucl Med. 2021 Jan 15. pii: jnumed.120.260950. doi: 10.2967/jnumed.120.260950.
PubMed

GUZIK P, Fang HY, Deberle LM, Benesova M, et al
Identification of a PET Radiotracer for Imaging of the Folate Receptor-alpha - A Potential Tool to Select Patients for Targeted Tumor Therapy.
J Nucl Med. 2021 Jan 15. pii: jnumed.120.255760. doi: 10.2967/jnumed.120.255760.
PubMed Abstract available

CHUGANI HT
HYPERMETABOLISM ON PEDIATRIC POSITRON EMISSION TOMOGRAPHY SCANS OF BRAIN GLUCOSE METABOLISM: What does it signify?
J Nucl Med. 2021 Jan 15. pii: jnumed.120.256081. doi: 10.2967/jnumed.120.256081.
PubMed Abstract available

WHITMAN J, Allen IE, Bergsland EK, Suh IA, et al
Assessment and comparison of fluorocholine PET and sestamibi scans in identifying parathyroid adenomas: a meta-analysis.
J Nucl Med. 2021 Jan 15. pii: jnumed.120.257303. doi: 10.2967/jnumed.120.257303.
PubMed Abstract available

MARKOWSKI MC, Velho PI, Eisenberger MA, Pomper MG, et al
Detection of Early Progression with (18)F-DCFPyL PET/CT in Men with Metastatic Castration-Resistant Prostate Cancer Receiving Bipolar Androgen Therapy.
J Nucl Med. 2021 Jan 15. pii: jnumed.120.259226. doi: 10.2967/jnumed.120.259226.
PubMed Abstract available

WIBMER AG, Morris MJ, Gonen M, Zheng J, et al
QUANTIFICATION OF METASTATIC PROSTATE CANCER WHOLE-BODY TUMOR BURDEN WITH FDG PET PARAMETERS AND ASSOCIATIONS WITH OVERALL SURVIVAL AFTER FIRST LINE ABIRATERONE OR ENZALUTAMIDE: A SINGLE- CENTER RETROSPECTIVE COHORT STUDY.
J Nucl Med. 2021 Jan 8. pii: jnumed.120.256602. doi: 10.2967/jnumed.120.256602.
PubMed Abstract available

Humana Decision to Deny PET/CT Coverage.
J Nucl Med. 2021;62:20N.
PubMed

VALI R, Alessio A, Balza R, Borgwardt L, et al
SNMMI Procedure Standard/EANM Practice Guideline on Pediatric (18)F-FDG PET/CT for Oncology 1.0.
J Nucl Med. 2021;62:99-110.
PubMed Abstract available

WAHL RL, Chareonthaitawee P, Clarke B, Drzezga A, et al
Mars Shot for Nuclear Medicine, Molecular Imaging, and Molecularly Targeted Radiopharmaceutical Therapy.
J Nucl Med. 2021;62:6-14.
PubMed Abstract available

CZERNIN J, Iagaru A
Humana and (18)F-FDG PET/CT: Another Sequel to the Injustice of Being Judged by the Errors of Others.
J Nucl Med. 2021;62:1-2.
PubMed

LAFFON E, Marthan R
Distribution Volume of (18)F-BMS-986192 in NSCLC Patients.
J Nucl Med. 2021;62:144.
PubMed

BUVAT I, Herrmann K, Stremitzer A, Tobia K, et al
Irene Buvat and Ken Herrmann Talk with Alexander Stremitzer, Kevin Tobia, and Aileen Nielsen.
J Nucl Med. 2021;62:3-5.
PubMed

PRICE WN 2ND, Gerke S, Cohen IG
How Much Can Potential Jurors Tell Us About Liability for Medical Artificial Intelligence?
J Nucl Med. 2021;62:15-16.
PubMed

TOBIA K, Nielsen A, Stremitzer A
When Does Physician Use of AI Increase Liability?
J Nucl Med. 2021;62:17-21.
PubMed Abstract available

CAPOBIANCO N, Meignan M, Cottereau AS, Vercellino L, et al
Deep-Learning (18)F-FDG Uptake Classification Enables Total Metabolic Tumor Volume Estimation in Diffuse Large B-Cell Lymphoma.
J Nucl Med. 2021;62:30-36.
PubMed Abstract available

ZIESSMAN HA, Jeyasingam M, Khan AU, McMahan Z, et al
Experience with Esophagogastrointestinal Transit Scintigraphy in the Initial 229 Patients: Multiple Regions of Dysmotility Are Common.
J Nucl Med. 2021;62:115-122.
PubMed Abstract available

December 2020

FRANCIS R, Bailey D, Hofman MS, Scott A, et al
The Australasian Radiopharmaceutical Trials Network (ARTnet) - Clinical Trials, Evidence and Opportunity.
J Nucl Med. 2020 Dec 31. pii: jnumed.120.258152. doi: 10.2967/jnumed.120.258152.
PubMed

CERCI JJ, Bogoni M, Cerci RJ, Masukawa M, et al
PET/CT guided biopsy of suspected lung lesions requires less rebiopsy than CT guided biopsy due to inconclusive results.
J Nucl Med. 2020 Dec 31. pii: jnumed.120.252403. doi: 10.2967/jnumed.120.252403.
PubMed Abstract available

WALKER MD, Bradley KM, McGowan DR
Data-Driven Respiratory Motion Correction in Clinical PET - A Turning Point.
J Nucl Med. 2020 Dec 18. pii: jnumed.120.257022. doi: 10.2967/jnumed.120.257022.
PubMed

GOTO T, Kikuchi S, Mori K, Nakayama T, et al
Cardiac Beta-Adrenergic Receptor Downregulation, Evaluated by Cardiac Positron Emission Tomography, in Chronotropic Incompetence.
J Nucl Med. 2020 Dec 18. pii: jnumed.120.253419. doi: 10.2967/jnumed.120.253419.
PubMed Abstract available

DEVASIA T, Dewaraja YK, Frey KA, Wong KK, et al
A novel time-activity information sharing approach using nonlinear mixed models for patient-specific dosimetry with reduced imaging time points: application in SPECT/CT imaging post-(177)Lu-DOTATATE.
J Nucl Med. 2020 Dec 18. pii: jnumed.120.256255. doi: 10.2967/jnumed.120.256255.
PubMed Abstract available

WANG C, Leach BI, Lister D, Adams SR, et al
Metallo-Fluorocarbon Nanoemulsion for Inflammatory Macrophage Detection via PET and MRI.
J Nucl Med. 2020 Dec 4. pii: jnumed.120.255273. doi: 10.2967/jnumed.120.255273.
PubMed Abstract available

HICKS RJ, Roselt PJ, Kallur KG, Tothill RW, et al
State-of-the-Art: FAPI PET/CT-Will it end the hegemony of FDG in oncology?
J Nucl Med. 2020 Dec 4. pii: jnumed.120.256271. doi: 10.2967/jnumed.120.256271.
PubMed Abstract available

RONCALI E, Capala J, Benedict SH, Akabani G, et al
Overview of the First NRG-NCI Workshop on Dosimetry of Systemic Radiopharmaceutical Therapy (RPT).
J Nucl Med. 2020 Dec 4. pii: jnumed.120.255547. doi: 10.2967/jnumed.120.255547.
PubMed Abstract available

VAN DONGEN GAMS, Beaino W, Windhorst AD, Zwezerijnen GJC, et al
The navigating and de-risking role of (89)Zr-immuno-PET in the development of biopharmaceuticals.
J Nucl Med. 2020 Dec 4. pii: jnumed.119.239558. doi: 10.2967/jnumed.119.239558.
PubMed Abstract available

KROENKE M, Mirzoyan L, Horn T, Peeken JC, et al
Matched-pair comparison of (68)Ga-PSMA-11 and (18)F-rhPSMA-7 PET/CT in patients with primary and biochemical recurrence of prostate cancer: frequency of non-tumor related uptake and tumor positivity.
J Nucl Med. 2020 Dec 4. pii: jnumed.120.251447. doi: 10.2967/jnumed.120.251447.
PubMed Abstract available

TANNER JA, Rabinovici GD
Relationship Between Tau and Cognition in the Evolution of Alzheimer's Disease: New Insights from Tau PET.
J Nucl Med. 2020 Dec 4. pii: jnumed.120.257824. doi: 10.2967/jnumed.120.257824.
PubMed

HOPE TA
Updates to the Appropriate-Use Criteria for Somatostatin Receptor PET.
J Nucl Med. 2020;61:1764.
PubMed

CARSON RE
Quantitative Cerebral Blood Flow with PET in the 1980s: Going with the Flow.
J Nucl Med. 2020;61.
PubMed

WEBER WA, Czernin J, Anderson CJ, Badawi RD, et al
The Future of Nuclear Medicine, Molecular Imaging, and Theranostics.
J Nucl Med. 2020;61.
PubMed

CATANA C
A Stepping-Stone to Fully Integrated Whole-Body PET/MRI.
J Nucl Med. 2020;61.
PubMed

BARTHEL H
Switching on Brain PET to Light Up Amyloid Pathology In Vivo.
J Nucl Med. 2020;61.
PubMed

The 60th Anniversary Issue of The Journal of Nuclear Medicine.
J Nucl Med. 2020;61.
PubMed

PAGANELLI G, Matteucci F
Importance of PET with (68)Ga-Labeled Somatostatin Analogs.
J Nucl Med. 2020;61.
PubMed

STUSCHKE M, Pottgen C
(18)F-FDG PET/CT for Target Volume Contouring in Lung Cancer Radiotherapy.
J Nucl Med. 2020;61.
PubMed

TAI YC
Small-Animal PET: A Technology That Changed Our Field.
J Nucl Med. 2020;61.
PubMed

FOWLER JS
(18)F-FDG Radiosynthesis: A Landmark in the History of PET.
J Nucl Med. 2020;61.
PubMed

POLVOY I, Flavell RR, Rosenberg OS, Ohliger MA, et al
Nuclear Imaging of Bacterial Infection: The State of the Art and Future Directions.
J Nucl Med. 2020;61:1708-1716.
PubMed Abstract available

A Conversation Between Frans van Houten and Ken Herrmann.
J Nucl Med. 2020;61:1697-1700.
PubMed

CULLINANE C, Jeffery CM, Roselt PD, van Dam EM, et al
Peptide Receptor Radionuclide Therapy with (67)Cu-CuSarTATE Is Highly Efficacious Against a Somatostatin-Positive Neuroendocrine Tumor Model.
J Nucl Med. 2020;61:1800-1805.
PubMed Abstract available

SACHER C, Blume T, Beyer L, Biechele G, et al
Asymmetry of Fibrillar Plaque Burden in Amyloid Mouse Models.
J Nucl Med. 2020;61:1825-1831.
PubMed Abstract available

TOMS J, Kogler J, Maschauer S, Daniel C, et al
Targeting Fibroblast Activation Protein: Radiosynthesis and Preclinical Evaluation of an (18)F-Labeled FAP Inhibitor.
J Nucl Med. 2020;61:1806-1813.
PubMed Abstract available

BERMAN DS, Rozanski A
Pharmacologic Stress Testing: Its Roots, Its Impact, and Its Future.
J Nucl Med. 2020;61.
PubMed

HOFMAN MS
Prostate-Specific Membrane Antigen: The Target of the Decade, from Biochemical Recurrence to Widespread Adoption.
J Nucl Med. 2020;61.
PubMed

STRAUSS HW
Establishing a Clinical Role for Bone Scans.
J Nucl Med. 2020;61.
PubMed

HICKS RJ, Hoekstra OS
PERCISTence: Strength or Stubbornness?
J Nucl Med. 2020;61.
PubMed

LAMMERTSMA AA
On the Origin of Hybrid Imaging.
J Nucl Med. 2020;61.
PubMed

BODEI L
Somatostatin Receptor Scintigraphy: Blazing in Indium and Quenching in Gallium.
J Nucl Med. 2020;61.
PubMed

SCHWAIGER M
From (201)Tl to (99m)Tc-Sestamibi.
J Nucl Med. 2020;61.
PubMed

November 2020

SHIYAM SUNDAR LK, Iommi D, Muzik O, Chalampalakis Z, et al
Conditional Generative Adversarial Networks (cGANs) aided motion correction of dynamic (18)F-FDG PET brain studies.
J Nucl Med. 2020 Nov 27. pii: jnumed.120.248856. doi: 10.2967/jnumed.120.248856.
PubMed Abstract available

ZHAO N, Huang Y, Wang YH, Muir RK, et al
Ferronostics: Measuring Tumoral Ferrous Iron with PET to Predict Sensitivity to Iron-Targeted Cancer Therapies.
J Nucl Med. 2020 Nov 27. pii: jnumed.120.252460. doi: 10.2967/jnumed.120.252460.
PubMed Abstract available

PACKARD RRS, Lazewatsky JL, Orlandi C, Maddahi J, et al
Diagnostic Performance of PET vs. SPECT Myocardial Perfusion Imaging in Patients with Smaller Left Ventricles: a Substudy of the (18)F-Flurpiridaz Phase-III Clinical Trial.
J Nucl Med. 2020 Nov 27. pii: jnumed.120.252007. doi: 10.2967/jnumed.120.252007.
PubMed Abstract available

BOURLA AB, Herrmann K
Real-World Data as an Evidence Source in Nuclear Medicine.
J Nucl Med. 2020 Nov 27. pii: jnumed.120.258665. doi: 10.2967/jnumed.120.258665.
PubMed

RAY S, Lisok A, Minn IL, Josefsson A, et al
Preclinical evaluation of (213)Bi-/(225)Ac-labeled low-molecular-weight compounds for radiopharmaceutical therapy of prostate cancer.
J Nucl Med. 2020 Nov 27. pii: jnumed.120.256388. doi: 10.2967/jnumed.120.256388.
PubMed Abstract available

KURCH L, Andreas H, Georgi TW, Rekowski J, et al
Interim positron emission tomography in diffuse large B-cell lymphoma.
J Nucl Med. 2020 Nov 27. pii: jnumed.120.255034. doi: 10.2967/jnumed.120.255034.
PubMed Abstract available

CZERNIN J, Iagaru A
Humana and (18)F-FDG PET/CT: Another Sequel to the Injustice of Being Judged by the Errors of Others.
J Nucl Med. 2020 Nov 13. pii: jnumed.120.260208. doi: 10.2967/jnumed.120.260208.
PubMed

CHANTADISAI M, Buschner G, Kronke M, Rauscher I, et al
Positive predictive value and correct detection rate of (18)F-rhPSMA-7 PET in biochemically recurrent prostate cancer validated by composite reference standard.
J Nucl Med. 2020 Nov 13. pii: jnumed.120.255661. doi: 10.2967/jnumed.120.255661.
PubMed Abstract available

CECCON G, Lohmann P, Werner JM, Tscherpel C, et al
Early treatment response assessment using (18)F-FET PET compared to contrast-enhanced MRI in glioma patients following adjuvant temozolomide chemotherapy.
J Nucl Med. 2020 Nov 6. pii: jnumed.120.254243. doi: 10.2967/jnumed.120.254243.
PubMed Abstract available

LEVI J, Goth S, Huynh L, Lam T, et al
(18)F-FAraG PET for CD8 Profiling of Tumors and Assessment of Immunomodulation by Chemotherapy.
J Nucl Med. 2020 Nov 6. pii: jnumed.120.249078. doi: 10.2967/jnumed.120.249078.
PubMed Abstract available

MEIJER D, Donswijk ML, Bodar YJL, van Leeuwen PJ, et al
Biochemical Persistence of Prostate-specific Antigen after Robot-assisted Laparoscopic Radical Prostatectomy: Tumor localizations using PSMA PET/CT imaging.
J Nucl Med. 2020 Nov 6. pii: jnumed.120.252528. doi: 10.2967/jnumed.120.252528.
PubMed Abstract available

TOWNSEND D, Beyer T, Czernin J
20 Years of PET/CT: A Conversation with David Townsend and Thomas Beyer.
J Nucl Med. 2020;61:1541-1543.
PubMed

CARTER LM, Henry KE, Platzman A, Lewis JS, et al
3D-Printable Platform for High-Throughput Small-Animal Imaging.
J Nucl Med. 2020;61:1691-1692.
PubMed

MAIRINGER S, Sake JA, Hernandez Lozano I, Filip T, et al
Assessing the Activity of Multidrug Resistance-Associated Protein 1 at the Lung Epithelial Barrier.
J Nucl Med. 2020;61:1650-1657.
PubMed Abstract available

SUURS FV, Lorenczewski G, Stienen S, Friedrich M, et al
The Biodistribution of a CD3 and EpCAM Bispecific T-Cell Engager Is Driven by the CD3 Arm.
J Nucl Med. 2020;61:1594-1601.
PubMed Abstract available

October 2020

HOU X, Brosch J, Uribe C, Desy A, et al
Feasibility of single-time-point dosimetry for radiopharmaceutical therapies.
J Nucl Med. 2020 Oct 30. pii: jnumed.120.254656. doi: 10.2967/jnumed.120.254656.
PubMed Abstract available

KOSTYSZYN D, Fechter T, Bartl N, Grosu AL, et al
Intraprostatic Tumour Segmentation on PSMA-PET Images in Patients with Primary Prostate Cancer with a Convolutional Neural Network.
J Nucl Med. 2020 Oct 30. pii: jnumed.120.254623. doi: 10.2967/jnumed.120.254623.
PubMed Abstract available

FRANC BL, Iagaru A
Letter to the Editor: "Disparities in PET imaging for prostate cancer at a tertiary academic medical center".
J Nucl Med. 2020 Oct 30. pii: jnumed.120.258160. doi: 10.2967/jnumed.120.258160.
PubMed

ALUICIO-SARDUY E, Barnhart TE, Weichert J, Hernandez R, et al
Cyclotron produced (132)La as a PET imaging surrogate of therapeutic (225)Ac.
J Nucl Med. 2020 Oct 30. pii: jnumed.120.255794. doi: 10.2967/jnumed.120.255794.
PubMed Abstract available

MAMMATAS LH, Yaqub M, Hendrikse NH, Hoekstra OS, et al
(11)C-sorafenib and (15)O-H2O PET for early evaluation of sorafenib therapy.
J Nucl Med. 2020 Oct 30. pii: jnumed.120.251611. doi: 10.2967/jnumed.120.251611.
PubMed Abstract available

ROHRICH M, Naumann P, Giesel FL, Choyke P, et al
Impact of (68)Ga-FAPI-PET/CT imaging on the therapeutic management of primary and recurrent pancreatic ductal adenocarcinomas.
J Nucl Med. 2020 Oct 23. pii: jnumed.120.253062. doi: 10.2967/jnumed.120.253062.
PubMed Abstract available

BLAZHENETS G, Frings L, Sorensen A, Meyer PT, et al
Principal components analysis based measures of PET data closely reflect neuropathological staging schemes.
J Nucl Med. 2020 Oct 23. pii: jnumed.120.252783. doi: 10.2967/jnumed.120.252783.
PubMed Abstract available

GOLAN S, Aviv T, Groshar D, Yakimov M, et al
Dynamic (68)Ga-PSMA-11 PET/CT for the primary evaluation of localized renal mass: a prospective study.
J Nucl Med. 2020 Oct 23. pii: jnumed.120.251272. doi: 10.2967/jnumed.120.251272.
PubMed Abstract available

BINDERUP T, Knigge U, Johnbeck CB, Loft A, et al
(18)F-FDG-PET is superior to WHO grading as prognostic tool in neuroendocrine neoplasms and useful in guiding peptide receptor radionuclide therapy: a prospective 10-year follow-up study of 166 patients.
J Nucl Med. 2020 Oct 16. pii: jnumed.120.244798. doi: 10.2967/jnumed.120.244798.
PubMed Abstract available

GERARD SK
PET/MRI versus PET/CT for Whole-Body Staging.
J Nucl Med. 2020 Oct 9. pii: jnumed.120.256453. doi: 10.2967/jnumed.120.256453.
PubMed

CHRISTENSEN TN, Langer SW, Persson GF, Larsen KR, et al
(18)F-FLT-PET/CT adds value to (18)F-FDG-PET/CT for diagnosing relapse after definitive radiotherapy in patients with lung cancer. Results of a prospective clinical trial.
J Nucl Med. 2020 Oct 9. pii: jnumed.120.247742. doi: 10.2967/jnumed.120.247742.
PubMed Abstract available

LODGE MA, Lesniak W, Gorin MA, Pienta KJ, et al
Measurement of PET Quantitative Bias In Vivo.
J Nucl Med. 2020 Oct 9. pii: jnumed.120.251397. doi: 10.2967/jnumed.120.251397.
PubMed Abstract available

PRIOR JO, Mirzaei S, Gnesin S, Nicod Lalonde M, et al
Dose optimization in pediatric studies: Why this is important and can benefit every nuclear medicine department.
J Nucl Med. 2020 Oct 9. pii: jnumed.120.254193. doi: 10.2967/jnumed.120.254193.
PubMed

VIDAL-SICART S, Rioja ME, Prieto A, Goni E, et al
Sentinel Lymph Node Biopsy in breast cancer with (99m)Tc-Tilmanocept: A novel tracer in the real life. A multicenter study.
J Nucl Med. 2020 Oct 9. pii: jnumed.120.252064. doi: 10.2967/jnumed.120.252064.
PubMed Abstract available

SPENCER BA, Berg E, Schmall JP, Omidvari N, et al
Performance evaluation of the uEXPLORER Total-body PET/CT scanner based on NEMA NU 2-2018 with additional tests to characterize long axial field-of-view PET scanners.
J Nucl Med. 2020 Oct 2. pii: jnumed.120.250597. doi: 10.2967/jnumed.120.250597.
PubMed Abstract available

CRANDALL JP, Fraum TJ, Lee M, Jiang L, et al
Repeatability of (18)F-FDG PET Radiomic Features in Cervical Cancer.
J Nucl Med. 2020 Oct 2. pii: jnumed.120.247999. doi: 10.2967/jnumed.120.247999.
PubMed Abstract available

YAMADA S, Tsuyoshi H, Yamamoto M, Tsujikawa T, et al
Prognostic value of 16alpha-[(18)F]-fluoro-17beta-estradiol positron emission tomography as a predictor of disease outcome in endometrial cancer: A prospective study.
J Nucl Med. 2020 Oct 2. pii: jnumed.120.244319. doi: 10.2967/jnumed.120.244319.
PubMed Abstract available

MARIANI G, Tonacchera M, Grosso M, Orsolini F, et al
The role of nuclear medicine in the clinical management of benign thyroid disorders. Part 1. Hyperthyroidism.
J Nucl Med. 2020 Oct 2. pii: jnumed.120.243170. doi: 10.2967/jnumed.120.243170.
PubMed Abstract available

JACENE HA
2020 SNMMI Highlights Lecture: General Nuclear Medicine and Molecular Imaging.
J Nucl Med. 2020;61:17N-23N.
PubMed

BARTHEL H
First Tau PET Tracer Approved: Toward Accurate In Vivo Diagnosis of Alzheimer Disease.
J Nucl Med. 2020;61:1409-1410.
PubMed

SKALI H, Murthy VL, Paez D, Choi EM, et al
Guidance and Best Practices for Reestablishment of Non-Emergent Care in Nuclear Cardiology Laboratories During the Coronavirus Disease 2019 (COVID-19) Pandemic: An Information Statement from ASNC, IAEA, and SNMMI.
J Nucl Med. 2020;61:1534-1539.
PubMed

KOYCHEV I, Hofer M, Friedman N
Correlation of Alzheimer Disease Neuropathologic Staging with Amyloid and Tau Scintigraphic Imaging Biomarkers.
J Nucl Med. 2020;61:1413-1418.
PubMed Abstract available

MATTAY VS, Fotenos AF, Ganley CJ, Marzella L, et al
Brain Tau Imaging: Food and Drug Administration Approval of (18)F-Flortaucipir Injection.
J Nucl Med. 2020;61:1411-1412.
PubMed

DARR C, Harke NN, Radtke JP, Yirga L, et al
Intraoperative (68)Ga-PSMA Cerenkov Luminescence Imaging for Surgical Margins in Radical Prostatectomy: A Feasibility Study.
J Nucl Med. 2020;61:1500-1506.
PubMed Abstract available

September 2020

ZUKOTYNSKI K, Gaudet V, Uribe CF, Mathotaarachchi S, et al
Machine Learning in Nuclear Medicine: Part 2-Neural Networks and Clinical Aspects.
J Nucl Med. 2020 Sep 25. pii: jnumed.119.231837. doi: 10.2967/jnumed.119.231837.
PubMed Abstract available

BOYLE AJ, Tong J, Zoghbi S, Pike VW, et al
Repurposing [(11)C]PS13 for PET imaging of cyclooxygenase-1 (COX-1) in ovarian cancer xenograft mouse models.
J Nucl Med. 2020 Sep 25. pii: jnumed.120.249367. doi: 10.2967/jnumed.120.249367.
PubMed Abstract available

BUCKNOR MD, Lichtensztajn DY, Lin TK, Borno HT, et al
Disparities in PET imaging for prostate cancer at a tertiary academic medical center.
J Nucl Med. 2020 Sep 25. pii: jnumed.120.251751. doi: 10.2967/jnumed.120.251751.
PubMed Abstract available

FOSTER CC, Davis RA, Hausner SH, Sutcliffe JL, et al
alphalphavbeta6 targeted molecular PET/CT imaging of lung post SARS-CoV-2 infection.
J Nucl Med. 2020 Sep 18. pii: jnumed.120.255364. doi: 10.2967/jnumed.120.255364.
PubMed Abstract available

DAS JP, Vargas HA, Ghafoor S, Goh AC, et al
Clinical utility of (18)F-FDG PET/CT in staging and treatment planning of urachal adenocarcinoma.
J Nucl Med. 2020 Sep 18. pii: jnumed.120.251561. doi: 10.2967/jnumed.120.251561.
PubMed Abstract available

CHEN DL, Ballout S, Chen L, Cheriyan J, et al
Consensus recommendations on the use of (18)F-FDG PET/CT in lung disease.
J Nucl Med. 2020 Sep 18. pii: jnumed.120.244780. doi: 10.2967/jnumed.120.244780.
PubMed Abstract available

FAROLFI A, Hirmas N, Gafita A, Weber M, et al
PSMA-PET identifies PCWG3 target populations with superior accuracy and reproducibility when compared to conventional imaging: a multicenter retrospective study.
J Nucl Med. 2020 Sep 11. pii: jnumed.120.246603. doi: 10.2967/jnumed.120.246603.
PubMed Abstract available

STEPHENS DM, Li H, Schoder H, Friedberg J, et al
Reply to: Interim PET assessment of advanced Hodgkin Lymphoma: is it sufficient?
J Nucl Med. 2020 Sep 11. pii: jnumed.120.242685. doi: 10.2967/jnumed.120.242685.
PubMed

JUNG KH, Park JW, Lee JH, Lee EJ, et al
(89)Zr Labeled Anti-PD-L1 Antibody PET Monitors Gemcitabine Therapy-Induced Modulation of Tumor PD-L1 Expression.
J Nucl Med. 2020 Sep 11. pii: jnumed.120.250720. doi: 10.2967/jnumed.120.250720.
PubMed Abstract available

VALKEMA MJ, van der Wilk BJ, Eyck BM, Wijnhoven BPL, et al
Surveillance of clinically complete responders using serial (18)F-FDG PET/CT scans in patients with esophageal cancer after neoadjuvant chemoradiotherapy.
J Nucl Med. 2020 Sep 4. pii: jnumed.120.247981. doi: 10.2967/jnumed.120.247981.
PubMed Abstract available

HUANG Y, Zhao N, Wang YH, Truillet C, et al
The synthesis and structural requirements for measuring glucocorticoid receptor expression in vivo with (+/-)-(11)C-YJH08 PET.
J Nucl Med. 2020 Sep 4. pii: jnumed.120.249755. doi: 10.2967/jnumed.120.249755.
PubMed Abstract available

GALLDIKS N, Abdulla DS, Scheffler M, Wolpert F, et al
Treatment Monitoring of Immunotherapy and Targeted Therapy using (18)F-FET PET in Patients with Melanoma and Lung Cancer Brain Metastases: Initial Experiences.
J Nucl Med. 2020 Sep 4. pii: jnumed.120.248278. doi: 10.2967/jnumed.120.248278.
PubMed Abstract available

DORBALA S, Park MA, Cuddy S, Singh V, et al
Absolute Quantitation of Cardiac (99m)Tc-pyrophophate Using Cadmium Zinc Telluride-based SPECT/CT.
J Nucl Med. 2020 Sep 4. pii: jnumed.120.247312. doi: 10.2967/jnumed.120.247312.
PubMed Abstract available

IRAVANI A, Hicks RJ
Imaging the cancer immune environment and its response to pharmacological intervention- Part 2- The Role of Novel PET Agents.
J Nucl Med. 2020 Sep 4. pii: jnumed.120.248823. doi: 10.2967/jnumed.120.248823.
PubMed Abstract available

LI YR, Roach M 3rd
The Roach Equation: Value of Old Clinical Tools in the Era of New Molecular Imaging.
J Nucl Med. 2020;61:1292-1293.
PubMed

CASTELLO A, Lopci E
Reply: Diagnosis of Hyperprogressive Disease in Patients Treated with Checkpoint Inhibitors Using (18)F-FDG PET/CT.
J Nucl Med. 2020;61:1405.
PubMed

OSBORNE JR, Hope TA
A Conversation Between Joseph Osborne and Thomas Hope.
J Nucl Med. 2020;61:1275-1277.
PubMed

HENRY KE, Chaney AM, Nagle VL, Cropper HC, et al
Demarcation of Sepsis-Induced Peripheral and Central Acidosis with pH (Low) Insertion Cycle Peptide.
J Nucl Med. 2020;61:1361-1368.
PubMed Abstract available

August 2020

POLI GL, Coca MA, Torres LA, Fahey FH, et al
Developing and implementing an imaging optimization study in pediatric nuclear medicine: Experience and recommendations from an IAEA Coordinated Research Project.
J Nucl Med. 2020 Aug 28. pii: jnumed.120.244616. doi: 10.2967/jnumed.120.244616.
PubMed Abstract available

NAGANAWA M, Nabulsi NB, Henry S, Matuskey D, et al
First in Human Assessment of the Novel M1 Muscarinic Acetylcholine Receptor PET Radiotracer (11)C-LSN3172176.
J Nucl Med. 2020 Aug 28. pii: jnumed.120.246967. doi: 10.2967/jnumed.120.246967.
PubMed Abstract available

RYDEN T, van Essen M, Marin I, Svensson J, et al
Deep learning generation of synthetic intermediate projections improves (177)Lu SPECT images reconstructed with sparsely acquired projections.
J Nucl Med. 2020 Aug 28. pii: jnumed.120.245548. doi: 10.2967/jnumed.120.245548.
PubMed Abstract available

KESSLER L, Schlitter AM, Kroenke M, von Werder A, et al
First experience using F-18-flubrobenguane PET imaging in patients with the suspicion of pheochromocytoma or paraganglioma.
J Nucl Med. 2020 Aug 28. pii: jnumed.120.248021. doi: 10.2967/jnumed.120.248021.
PubMed Abstract available

SANCHEZ-CATASUS CA, Bohnen NI, Yeh FC, D'Cruz N, et al
Dopaminergic nigrostriatal connectivity in early Parkinson disease: in vivo neuroimaging study of (11)C-DTBZ PET combined with correlational tractography.
J Nucl Med. 2020 Aug 28. pii: jnumed.120.248500. doi: 10.2967/jnumed.120.248500.
PubMed Abstract available

WERNER RA, Derlin T, Rowe SP, Bundschuh L, et al
High Interobserver Agreement for the Standardized Reporting System SSTR-RADS 1.0 on Somatostatin Receptor PET/CT.
J Nucl Med. 2020 Aug 28. pii: jnumed.120.245464. doi: 10.2967/jnumed.120.245464.
PubMed Abstract available

NAGANAWA M, Li S, Nabulsi NB, Henry S, et al
First-in-human evaluation of (18)F-SynVesT-1, a novel radioligand for PET imaging of synaptic vesicle protein 2A.
J Nucl Med. 2020 Aug 28. pii: jnumed.120.249144. doi: 10.2967/jnumed.120.249144.
PubMed Abstract available

FILSS CP, Stegmayr C, Lohmann P, Galldiks N, et al
Reply to: Flare phenomenon in O-(2-[(18)F]-Fluoroethyl)-L-Tyrosine PET after resection of gliomas: potential contribution from postoperative ischemia.
J Nucl Med. 2020 Aug 28. pii: jnumed.120.251819. doi: 10.2967/jnumed.120.251819.
PubMed

MACASKILL MG, Stadulyte A, Williams L, Morgan TEF, et al
Quantification of macrophage-driven inflammation during myocardial infarction with (18)F-LW223, a novel TSPO radiotracer with binding independent of the rs6971 human polymorphism.
J Nucl Med. 2020 Aug 28. pii: jnumed.120.243600. doi: 10.2967/jnumed.120.243600.
PubMed Abstract available

KUMAR M, Salem K, Jeffery JJ, Yan Y, et al
Longitudinal molecular imaging of progesterone receptor reveals early differential response to endocrine therapy in breast cancer with an activating ESR1 mutation.
J Nucl Med. 2020 Aug 28. pii: jnumed.120.249508. doi: 10.2967/jnumed.120.249508.
PubMed Abstract available

NICOLAY NH, Ruhle A, Wiedenmann N, Niedermann G, et al
Lymphocyte Infiltration Determines the Hypoxia-Dependent Response to Definitive Chemoradiation in Head-and-Neck Cancer - Results from a Prospective Imaging Trial.
J Nucl Med. 2020 Aug 28. pii: jnumed.120.248633. doi: 10.2967/jnumed.120.248633.
PubMed Abstract available

SIITONEN R, Moisio OA, Lankinen P, Li XG, et al
First-in-Human Study of (68)Ga-DOTA-Siglec-9, PET Ligand Targeting Vascular Adhesion Protein 1.
J Nucl Med. 2020 Aug 17. pii: jnumed.120.250696. doi: 10.2967/jnumed.120.250696.
PubMed Abstract available

SPRUTE K, Kramer V, Koerber S, Meneses M, et al
Diagnostic accuracy of (18)F-PSMA-1007-PET/CT imaging for lymph node staging of prostate carcinoma in primary and biochemical recurrence.
J Nucl Med. 2020 Aug 17. pii: jnumed.120.246363. doi: 10.2967/jnumed.120.246363.
PubMed Abstract available

VAN ES SC, Velleman T, Elias SG, Bensch F, et al
Assessment of Bone Lesions with (18)F-FDG-PET Compared to (99m)Technetium Bone Scintigraphy Leads to Clinically Relevant Differences in Metastatic Breast Cancer Management.
J Nucl Med. 2020 Aug 17. pii: jnumed.120.244640. doi: 10.2967/jnumed.120.244640.
PubMed Abstract available

BRAGINA O, von Witting E, Garousi J, Zelchan R, et al
Phase I study of (99m)Tc-ADAPT6, a scaffold protein-based probe for visualization of HER2 expression in breast cancer.
J Nucl Med. 2020 Aug 17. pii: jnumed.120.248799. doi: 10.2967/jnumed.120.248799.
PubMed Abstract available

KOHLI P, Kelly VJ, Hibbert K, Corleis B, et al
PET Imaging Reveals Early Pulmonary Perfusion Abnormalities in HIV Infection Similar to Smoking.
J Nucl Med. 2020 Aug 6. pii: jnumed.120.245977. doi: 10.2967/jnumed.120.245977.
PubMed Abstract available

REGINE K, Wittig T, Georgi TW, Kurch L, et al
Comparison of interim PET response to second-line vs. to first-line treatment in classical Hodgkin lymphoma - contribution to the development of response criteria for relapsed or progressive disease.
J Nucl Med. 2020 Aug 6. pii: jnumed.120.247924. doi: 10.2967/jnumed.120.247924.
PubMed Abstract available

FOSBOL MO, Kurbegovic S, Johannesen HH, Roder MA, et al
Urokinase Plasminogen Activator Receptor (uPAR) PET/MRI of Prostate Cancer for Non-invasive Evaluation of Aggressiveness: a Prospective Phase II Clinical Trial Comparing with Gleason Score.
J Nucl Med. 2020 Aug 6. pii: jnumed.120.248120. doi: 10.2967/jnumed.120.248120.
PubMed Abstract available

SCHINDLER TH, Bateman TM, Berman DS, Chareonthaitawee P, et al
Appropriate Use Criteria for PET Myocardial Perfusion Imaging.
J Nucl Med. 2020;61:1221-1265.
PubMed

CZERNIN J
The Future of Nuclear Medicine Depends on the Quality of Its Research: Researchers at the University of Heidelberg Receive the Award for Best Article of the Year.
J Nucl Med. 2020;61:1087.
PubMed

BODEI L, Bergsland E, de Herder WW, Ferone D, et al
Peptide Receptor Radionuclide Therapy During the COVID-19 Pandemic: Are There Any Concerns?
J Nucl Med. 2020;61:1094-1095.
PubMed

MARTIN KC, Czernin J
A Conversation Between Kelsey Martin and Johannes Czernin.
J Nucl Med. 2020;61:1091-1093.
PubMed

ZINDEL C, Herrmann K
A Conversation Between Christoph Zindel and Ken Herrmann.
J Nucl Med. 2020;61:1088-1090.
PubMed

MUELLER JJ, Dauer LT, Murali R, Iasonos A, et al
Positron Lymphography via Intracervical (18)F-FDG Injection for Presurgical Lymphatic Mapping in Cervical and Endometrial Malignancies.
J Nucl Med. 2020;61:1123-1130.
PubMed Abstract available

TRAN-GIA J, Salas-Ramirez M, Lassmann M
What You See Is Not What You Get: On the Accuracy of Voxel-Based Dosimetry in Molecular Radiotherapy.
J Nucl Med. 2020;61:1178-1186.
PubMed Abstract available

CISTARO A, Quartuccio N, Piccardo A, Fania P, et al
(18)F-FDG PET Identifies Altered Brain Metabolism in Patients with Cri du Chat Syndrome.
J Nucl Med. 2020;61:1195-1199.
PubMed Abstract available

POLLARD JH, Raman C, Zakharia Y, Tracy CR, et al
Quantitative Test-Retest Measurement of (68)Ga-PSMA-HBED-CC in Tumor and Normal Tissue.
J Nucl Med. 2020;61:1145-1152.
PubMed Abstract available

July 2020

CHODYLA M, Demircioglu A, Schaarschmidt BM, Bertram S, et al
Evaluation of (18)F-FDG PET and DWI datasets for the prediction of therapy response of soft tissues sarcomas under neoadjuvant isolated limb perfusion.
J Nucl Med. 2020 Jul 31. pii: jnumed.120.248260. doi: 10.2967/jnumed.120.248260.
PubMed Abstract available

THERRIAULT J, Benedet A, Pascoal TA, Savard M, et al
Determining Amyloid-beta positivity using [(18)F]AZD4694 PET imaging.
J Nucl Med. 2020 Jul 31. pii: jnumed.120.245209. doi: 10.2967/jnumed.120.245209.
PubMed Abstract available

GRIMALDI S, Lagarde S, Harle JR, Boucraut J, et al
Autoimmune encephalitis concomitant with SARS-CoV-2 infection: insight from (18)F-FDG PET imaging and neuronal autoantibodies.
J Nucl Med. 2020 Jul 24. pii: jnumed.120.249292. doi: 10.2967/jnumed.120.249292.
PubMed Abstract available

FREUDENBERG LS, Paez D, Giammarile F, Cerci JJ, et al
Global Impact of COVID-19 on Nuclear Medicine Departments: An International Survey in April 2020.
J Nucl Med. 2020 Jul 24. pii: jnumed.120.249821. doi: 10.2967/jnumed.120.249821.
PubMed Abstract available

LAURELL GL, Plaven-Sigray P, Jucaite A, Varrone A, et al
Non-displaceable binding is a potential confounding factor in (11)CPBR28 TSPO PET studies.
J Nucl Med. 2020 Jul 17. pii: jnumed.120.243717. doi: 10.2967/jnumed.120.243717.
PubMed Abstract available

KULTERER OC, Pfaff S, Wadsak W, Garstka N, et al
A microdosing study with (99m)Tc-PHC-102 for the SPECT/CT imaging of primary and metastatic lesions in renal cell carcinoma patients.
J Nucl Med. 2020 Jul 17. pii: jnumed.120.245530. doi: 10.2967/jnumed.120.245530.
PubMed Abstract available

ULANER GA, Jhaveri K, Chardarlapaty S, Hatzoglou V, et al
Head-to-head evaluation of (18)F-FES and (18)F-FDG PET/CT in metastatic invasive lobular breast cancer.
J Nucl Med. 2020 Jul 17. pii: jnumed.120.247882. doi: 10.2967/jnumed.120.247882.
PubMed Abstract available

NABAVIZADEH SA, Nasrallah IM, Pryma DA
Flare phenomenon in O-(2-[(18)F]-Fluoroethyl)-L-Tyrosine PET after resection of gliomas: potential contribution from postoperative ischemia.
J Nucl Med. 2020 Jul 9. pii: jnumed.120.251116. doi: 10.2967/jnumed.120.251116.
PubMed

CUTLER CS, Bailey EA, Kumar V, Schwarz SW, et al
Global Issues of Radiopharmaceutical Access and Availability: a Nuclear Medicine Global Initiative Project.
J Nucl Med. 2020 Jul 9. pii: jnumed.120.247197. doi: 10.2967/jnumed.120.247197.
PubMed Abstract available

HARADA R, Hayakawa Y, Ezura M, Lerdsirisuk P, et al
(18)F-SMBT-1: A Selective and Reversible Positron-Emission Tomography Tracer for Monoamine Oxidase-B Imaging.
J Nucl Med. 2020 Jul 9. pii: jnumed.120.244400. doi: 10.2967/jnumed.120.244400.
PubMed Abstract available

TATEKAWA H, Hagiwara A, Yao J, Oughourlian TC, et al
Voxel-Wise and Patient-Wise Correlation of (18)F-FDOPA PET, rCBV, and ADC in Treatment-Naive Diffuse Gliomas with Different Molecular Subtypes.
J Nucl Med. 2020 Jul 9. pii: jnumed.120.247411. doi: 10.2967/jnumed.120.247411.
PubMed Abstract available

NAGANAWA M, Gallezot JD, Finnema S, Matuskey D, et al
Simplified Quantification of (11)C-UCB-J PET Evaluated in a Large Human Cohort.
J Nucl Med. 2020 Jul 9. pii: jnumed.120.243949. doi: 10.2967/jnumed.120.243949.
PubMed Abstract available

RUSSELL J, Grkovski M, O'Donoghue IJ, Kalidindi TM, et al
Predicting gemcitabine delivery by (18)F-FAC PET in murine models of pancreatic cancer.
J Nucl Med. 2020 Jul 9. pii: jnumed.120.246926. doi: 10.2967/jnumed.120.246926.
PubMed Abstract available

SPANGLER-BICKELL MG, Deller TW, Bettinardi V, Jansen F, et al
Ultra-Fast List-Mode Reconstruction of Short PET Frames and Example Applications.
J Nucl Med. 2020 Jul 9. pii: jnumed.120.245597. doi: 10.2967/jnumed.120.245597.
PubMed Abstract available

JAIN P, Chaney A, Carlson ML, Jackson IM, et al
Neuroinflammation PET imaging: Current opinion and future directions.
J Nucl Med. 2020 Jul 3. pii: jnumed.119.229443. doi: 10.2967/jnumed.119.229443.
PubMed Abstract available

HAMMES J, Bischof GN, Bohn KP, Onur O, et al
One stop shop: Flortaucipir PET differentiates amyloid positive and negative forms of neurodegenerative diseases.
J Nucl Med. 2020 Jul 3. pii: jnumed.120.244061. doi: 10.2967/jnumed.120.244061.
PubMed Abstract available

BINI J, Carson RE, Cline GW
Reply to LTE: (11)C-(+)-PHNO Trapping Reversibility for Quantitative PET Imaging of Beta-Cell-Mass in Patients with Type-1 Diabetes.
J Nucl Med. 2020 Jul 3. pii: jnumed.120.250985. doi: 10.2967/jnumed.120.250985.
PubMed

VAN DEN WYNGAERT T, Elvas F, De Schepper S, Kennedy JA, et al
SPECT/CT - standing on the shoulders of giants, it is time to reach for the sky!
J Nucl Med. 2020 Jul 3. pii: jnumed.119.236943. doi: 10.2967/jnumed.119.236943.
PubMed Abstract available

ZUBAL IG
Time for a Next-Generation Nuclear Medicine Gamma Camera?
J Nucl Med. 2020;61:16N.
PubMed

MURTHY VL, Bateman TM, Chen W, Malhotra S, et al
Impact of the ISCHEMIA Trial on Stress Nuclear Myocardial Perfusion Imaging.
J Nucl Med. 2020;61:962-964.
PubMed

BODINI B, Poirion E, Tonietto M, Benoit C, et al
Individual Mapping of Innate Immune Cell Activation Is a Candidate Marker of Patient-Specific Trajectories of Worsening Disability in Multiple Sclerosis.
J Nucl Med. 2020;61:1043-1049.
PubMed Abstract available

KLINGLER S, Fay R, Holland JP
Light-Induced Radiosynthesis of (89)Zr-DFO-Azepin-Onartuzumab for Imaging the Hepatocyte Growth Factor Receptor.
J Nucl Med. 2020;61:1072-1078.
PubMed Abstract available

KNIGHT JC, Torres JB, Goldin R, Mosley M, et al
Early Detection in a Mouse Model of Pancreatic Cancer by Imaging DNA Damage Response Signaling.
J Nucl Med. 2020;61:1006-1013.
PubMed Abstract available

QUELVEN I, Monteil J, Sage M, Saidi A, et al
(212)Pb alpha-Radioimmunotherapy Targeting CD38 in Multiple Myeloma: A Preclinical Study.
J Nucl Med. 2020;61:1058-1065.
PubMed Abstract available

YU Q, Huang S, Wu Z, Zheng J, et al
Label-Free Visualization of Early Cancer Hepatic Micrometastasis and Intraoperative Image-Guided Surgery by Photoacoustic Imaging.
J Nucl Med. 2020;61:1079-1085.
PubMed Abstract available

June 2020

GIESEL F, Adeberg S, Syed M, Lindner T, et al
FAPI-74 PET/CT Using Either (18)F-AlF or Cold-kit (68)Ga-labeling: Biodistribution, Radiation Dosimetry and Tumor Delineation in Lung Cancer Patients.
J Nucl Med. 2020 Jun 26. pii: jnumed.120.245084. doi: 10.2967/jnumed.120.245084.
PubMed Abstract available

PETERSON LM, Kurland BF, Yan F, Novakova-Jiresova A, et al
(18)F-Fluoroestradiol ((18)F-FES)-PET imaging in a Phase II trial of vorinostat to restore endocrine sensitivity in ER+/HER2- metastatic breast cancer.
J Nucl Med. 2020 Jun 26. pii: jnumed.120.244459. doi: 10.2967/jnumed.120.244459.
PubMed Abstract available

VAN ROEKEL C, Bastiaannet R, Smits MLJ, Bruijnen RC, et al
Dose-effect relationships of holmium-166 radioembolization in colorectal cancer.
J Nucl Med. 2020 Jun 26. pii: jnumed.120.243832. doi: 10.2967/jnumed.120.243832.
PubMed Abstract available

NOTO RB
Diversity, not Divisiveness, is the Future of Nuclear Medicine.
J Nucl Med. 2020 Jun 23. pii: jnumed.120.250035. doi: 10.2967/jnumed.120.250035.
PubMed

CZERNIN J
Reply to: Diversity, not Divisiveness, is the Future of Nuclear Medicine.
J Nucl Med. 2020 Jun 23. pii: jnumed.120.250415. doi: 10.2967/jnumed.120.250415.
PubMed

SHAFFER T, Gambhir SS, Aalipour A, Schurch C, et al
PET imaging of the natural killer cell activation receptor NKp30.
J Nucl Med. 2020 Jun 12. pii: jnumed.119.233163. doi: 10.2967/jnumed.119.233163.
PubMed Abstract available

FERDINANDUS J, Barbato F, Chodyla M, Fendler WP, et al
Volumetric PET response assessment outperforms conventional criteria in patients receiving high-dose pembrolizumab for malignant mesothelioma.
J Nucl Med. 2020 Jun 12. pii: jnumed.120.245803. doi: 10.2967/jnumed.120.245803.
PubMed Abstract available

SHARMA R, Inglese M, Dubash S, Lu H, et al
Monitoring response to transarterial chemoembolization in hepatocellular carcinoma using (18)F-Fluorothymidine Positron Emission Tomography.
J Nucl Med. 2020 Jun 8. pii: jnumed.119.240598. doi: 10.2967/jnumed.119.240598.
PubMed Abstract available

LUO Y, Pan Q, Yang H, Peng L, et al
Fibroblast activation protein targeted PET/CT with (68)Ga-FAPI for imaging IgG4-related disease: comparison to (18)F-FDG PET/CT.
J Nucl Med. 2020 Jun 8. pii: jnumed.120.244723. doi: 10.2967/jnumed.120.244723.
PubMed Abstract available

KESNER AL
Data-driven motion correction in clinical PET - a joint accomplishment of creative academia and industry.
J Nucl Med. 2020 Jun 8. pii: jnumed.120.248187. doi: 10.2967/jnumed.120.248187.
PubMed

SCHMALL JP, Surti S, Otero H, Servaes S, et al
Investigating low-dose image quality in whole-body pediatric (18)F-FDG scans using TOF-PET/MRI.
J Nucl Med. 2020 Jun 1. pii: jnumed.119.240127. doi: 10.2967/jnumed.119.240127.
PubMed Abstract available

Guidance and best practices for nuclear cardiology laboratories during the coronavirus disease 2019 (COVID-19) pandemic: An Information Statement from ASNC and SNMMI.
J Nucl Med. 2020;61:784-791.
PubMed

COOK GJR, Goh V
Molecular Imaging of Bone Metastases and Their Response to Therapy.
J Nucl Med. 2020;61:799-806.
PubMed Abstract available

May 2020

PRATT EC, Isaac E, Stater E, Yang G, et al
Synthesis of novel PET tracer (124)I-trametinib for MAPK/ERK kinase distribution and resistance monitoring.
J Nucl Med. 2020 May 22. pii: jnumed.120.241901. doi: 10.2967/jnumed.120.241901.
PubMed Abstract available

WEBER M, Kurek CE, Barbato F, Eiber M, et al
PSMA-ligand PET for early castration-resistant prostate cancer: a retrospective single-center study.
J Nucl Med. 2020 May 22. pii: jnumed.120.245456. doi: 10.2967/jnumed.120.245456.
PubMed Abstract available

IRAVANI A, Hicks RJ
Imaging the cancer immune environment and its response to pharmacological intervention- Part 1- The role of FDG PET/CT.
J Nucl Med. 2020 May 22. pii: jnumed.119.234278. doi: 10.2967/jnumed.119.234278.
PubMed Abstract available

KLINGENBERG S, Jochumsen MR, Ulhoi BP, Fredsoe J, et al
(68)Ga-PSMA PET/CT for primary NM staging of high-risk prostate cancer.
J Nucl Med. 2020 May 22. pii: jnumed.120.245605. doi: 10.2967/jnumed.120.245605.
PubMed Abstract available

HEO GS, Bajpai G, Li W, Luehmann HP, et al
Targeted PET Imaging of Chemokine Receptor 2+ Monocytes and Macrophages in the Injured Heart.
J Nucl Med. 2020 May 22. pii: jnumed.120.244673. doi: 10.2967/jnumed.120.244673.
PubMed Abstract available

LOFT M, Carlsen EA, Johnbeck CB, Johannesen HH, et al
(64)Cu-DOTATATE PET in Patients with Neuroendocrine Neoplasms: Prospective, Head-to-Head Comparison of Imaging at 1 Hour and 3 Hours Post-Injection.
J Nucl Med. 2020 May 22. pii: jnumed.120.244509. doi: 10.2967/jnumed.120.244509.
PubMed Abstract available

DITTMANN H, Kaltenbach S, Weissinger M, Fiz F, et al
The prognostic value of quantitative bone scan SPECT/CT prior to (223)Ra treatment in metastatic castration-resistant prostate cancer (mCRPC).
J Nucl Med. 2020 May 22. pii: jnumed.119.240408. doi: 10.2967/jnumed.119.240408.
PubMed Abstract available

BAGUNA TORRES J, Mosley M, Koustoulidou S, Hopkins S, et al
Radiolabeled cCPE Peptides for SPECT Imaging of Claudin-4 Overexpression in Pancreatic Cancer.
J Nucl Med. 2020 May 15. pii: jnumed.120.243113. doi: 10.2967/jnumed.120.243113.
PubMed Abstract available

ABOIAN M, Huang SY, Pampaloni MH, Hawkins RA, et al
(124)I-MIBG PET-CT to monitor metastatic disease in children with relapsed neuroblastoma.
J Nucl Med. 2020 May 15. pii: jnumed.120.243139. doi: 10.2967/jnumed.120.243139.
PubMed Abstract available

BARTHEL H, Seibyl J, Lammertsma AA, Villemagne VL, et al
Exploiting the Full Potential of Beta-Amyloid and Tau PET Imaging for Drug Efficacy Testing.
J Nucl Med. 2020 May 15. pii: jnumed.119.228346. doi: 10.2967/jnumed.119.228346.
PubMed

SHI Z, Fu LP, Zhang N, Zhao X, et al
Amyloid PET in Dementia Syndromes: A Chinese Multicenter Study.
J Nucl Med. 2020 May 8. pii: jnumed.119.240325. doi: 10.2967/jnumed.119.240325.
PubMed Abstract available

REKOWSKI J, Huttmann A, Schmitz C, Muller SP, et al
Interim PET evaluation in diffuse large B-cell lymphoma employing published recommendations: Comparison of the Deauville 5-point scale and the DeltaSUVmax method.
J Nucl Med. 2020 May 8. pii: jnumed.120.244145. doi: 10.2967/jnumed.120.244145.
PubMed Abstract available

ZUBAL IG
Time for a Next-Generation Nuclear Medicine Gamma Camera? [NEWSLINE].
J Nucl Med. 2020 May 8. pii: jnumed.120.249219. doi: 10.2967/jnumed.120.249219.
PubMed

HARSINI S, Saprunoff H, Alden TM, Mohammadi B, et al
The effects of monosodium glutamate on PSMA radiotracer uptake in men with recurrent prostate cancer: a prospective, randomized, double-blind, placebo-controlled intra-individual imaging study.
J Nucl Med. 2020 May 8. pii: jnumed.120.246983. doi: 10.2967/jnumed.120.246983.
PubMed Abstract available

GORDON L
ABNM: Helping Diplomates and Trainees During the COVID-19 Pandemic.
J Nucl Med. 2020;61:13N.
PubMed

CZERNIN J
The Standard of Care: From Nuclear Radiology to Nuclear Medicine.
J Nucl Med. 2020;61:637.
PubMed

FENDLER WP, Ferdinandus J, Czernin J, Eiber M, et al
Impact of (68)Ga-PSMA-11 PET on the Management of recurrent Prostate Cancer in a Prospective Single-Arm Clinical Trial.
J Nucl Med. 2020 May 1. pii: jnumed.120.242180. doi: 10.2967/jnumed.120.242180.
PubMed Abstract available

STUTVOET TS, van der Veen EL, Kol A, Antunes IF, et al
Molecular imaging of PD-L1 expression and dynamics with the adnectin-based PET tracer (18)F-BMS-986192.
J Nucl Med. 2020 May 1. pii: jnumed.119.241364. doi: 10.2967/jnumed.119.241364.
PubMed Abstract available

RIPP I, Stadhouders T, Savio A, Goldhardt O, et al
Integrity of neurocognitive networks in dementing disorders as measured with simultaneous PET/fMRI.
J Nucl Med. 2020 May 1. pii: jnumed.119.234930. doi: 10.2967/jnumed.119.234930.
PubMed Abstract available

LOPEZ MORA DA, Flotats A, Fuentes-Ocampo F, Carrio I, et al
Reported differences between Digital and Analog PET/CT studies.
J Nucl Med. 2020 May 1. pii: jnumed.120.244608. doi: 10.2967/jnumed.120.244608.
PubMed

RULLMANN M, McLeod A, Grothe M, Sabri O, et al
Reshaping the amyloid buildup curve in Alzheimer's disease? - Partial volume effect correction of longitudinal amyloid PET data.
J Nucl Med. 2020 May 1. pii: jnumed.119.238477. doi: 10.2967/jnumed.119.238477.
PubMed Abstract available

CUDA TJ, Riddell AD, Liu C, Whitehall VL, et al
PET imaging quantifying (68)Ga-PSMA-11 uptake in metastatic colorectal cancer.
J Nucl Med. 2020 May 1. pii: jnumed.119.233312. doi: 10.2967/jnumed.119.233312.
PubMed Abstract available

CZERNIN J, Fanti S, Meyer PT, Allen-Auerbach M, et al
Nuclear Medicine Operations in the Times of COVID-19: Strategies, Precautions, and Experiences.
J Nucl Med. 2020;61:626-629.
PubMed

CARRIO I, Herrmann K
A Conversation Between Ignasi Carrio and Ken Herrmann.
J Nucl Med. 2020;61:638-640.
PubMed

O'NEILL E, Kersemans V, Allen PD, Terry SYA, et al
Imaging DNA Damage Repair In Vivo After (177)Lu-DOTATATE Therapy.
J Nucl Med. 2020;61:743-750.
PubMed Abstract available

KRATOCHWIL C, Giesel FL, Heussel CP, Kazdal D, et al
Patients Resistant Against PSMA-Targeting alpha-Radiation Therapy Often Harbor Mutations in DNA Damage-Repair-Associated Genes.
J Nucl Med. 2020;61:683-688.
PubMed Abstract available

ABBOTT EM, Falzone N, Lee BQ, Kartsonaki C, et al
The Impact of Radiobiologically-Informed Dose Prescription on the Clinical Benefit of Yttrium-90 SIRT in Colorectal Cancer Patients.
J Nucl Med. 2020 May 1. pii: jnumed.119.233650. doi: 10.2967/jnumed.119.233650.
PubMed Abstract available

April 2020

SEIFERT R, Herrmann K, Kleesiek J, Schafers MA, et al
Semi-automatically quantified tumor volume using Ga-68-PSMA-11-PET as biomarker for survival in patients with advanced prostate cancer.
J Nucl Med. 2020 Apr 24. pii: jnumed.120.242057. doi: 10.2967/jnumed.120.242057.
PubMed Abstract available

HERHAUS P, Lipkova J, Lammer F, Yakushev I, et al
CXCR4-targeted positron emission tomography imaging of central nervous system B-cell lymphoma.
J Nucl Med. 2020 Apr 24. pii: jnumed.120.241703. doi: 10.2967/jnumed.120.241703.
PubMed Abstract available

CHIU LW, Lawhn-Heath C, Behr S, Juarez R, et al
Factors predicting metastatic disease in (68)Ga-PSMA-11 PET positive osseous lesions in prostate cancer.
J Nucl Med. 2020 Apr 17. pii: jnumed.119.241174. doi: 10.2967/jnumed.119.241174.
PubMed Abstract available

JUENGLING FD, Maldonado A, Wuest F, Schindler TH, et al
The role of Nuclear Medicine for COVID-19 - Time to act now.
J Nucl Med. 2020 Apr 17. pii: jnumed.120.246611. doi: 10.2967/jnumed.120.246611.
PubMed

WERNER RA, Thackeray JT, Diekmann J, Weiberg D, et al
The Changing Face of Nuclear Cardiology: Guiding Cardiovascular Care towards Molecular Medicine.
J Nucl Med. 2020 Apr 17. pii: jnumed.119.240440. doi: 10.2967/jnumed.119.240440.
PubMed Abstract available

REYNOLDS JC, Maass-Moreno R, Thomas A, Ling A, et al
FDG-PET assessment of malignant pleural mesothelioma: Total Lesion volume and Total Lesion Glycolysis; the central role of volume.
J Nucl Med. 2020 Apr 13. pii: jnumed.119.238733. doi: 10.2967/jnumed.119.238733.
PubMed Abstract available

JAHANDIDEH A, Uotila S, Stahle M, Virta J, et al
Folate Receptor beta Targeted PET Imaging of Macrophages in Autoimmune Myocarditis.
J Nucl Med. 2020 Apr 13. pii: jnumed.119.241356. doi: 10.2967/jnumed.119.241356.
PubMed Abstract available

WEIDNER LD, Wakabayashi Y, Stolz LA, Collins MT, et al
PET imaging of phosphodiesterase-4 identifies affected dysplastic bone in McCune-Albright syndrome, a genetic mosaic disorder.
J Nucl Med. 2020 Apr 13. pii: jnumed.120.241976. doi: 10.2967/jnumed.120.241976.
PubMed Abstract available

WALKER MD, Morgan AJ, Bradley KM, McGowan DR, et al
Data Driven Respiratory Gating Outperforms Device-Based Gating for Clinical FDG PET/CT.
J Nucl Med. 2020 Apr 3. pii: jnumed.120.242248. doi: 10.2967/jnumed.120.242248.
PubMed Abstract available

HOFMAN MS
ProPSMA: a callout to the nuclear medicine community to change practice with prospective, high-quality data.
J Nucl Med. 2020 Apr 3. pii: jnumed.120.245647. doi: 10.2967/jnumed.120.245647.
PubMed

ALBANO D, Bertagna F, Bertolia M, Bosio G, et al
INCIDENTAL FINDINGS SUGGESTIVE OF COVID-19 IN ASYMPTOMATIC PATIENTS UNDERGOING NUCLEAR MEDICINE PROCEDURES IN A HIGH PREVALENCE REGION.
J Nucl Med. 2020 Apr 1. pii: jnumed.120.246256. doi: 10.2967/jnumed.120.246256.
PubMed Abstract available

ZUCKIER LS, Moadel RM, Haramati LB, Freeman L, et al
Diagnostic evaluation of pulmonary embolism during the COVID-19 pandemic.
J Nucl Med. 2020 Apr 1. pii: jnumed.120.245571. doi: 10.2967/jnumed.120.245571.
PubMed

SABOUR S
Myocardial Blood Flow and Myocardial Flow Reserve After Cardiac Transplantation: Mistakes in Diagnostic Value and Prognosis.
J Nucl Med. 2020;61:622.
PubMed

SUNDERLAND JJ, Czernin J, Hope T
A Conversation with John Sunderland, Johannes Czernin, and Thomas Hope.
J Nucl Med. 2020;61:477-479.
PubMed

MAYERHOEFER ME, Materka A, Langs G, Haggstrom I, et al
Introduction to Radiomics.
J Nucl Med. 2020;61:488-495.
PubMed Abstract available

SUNDERLAND JJ
The Academic NDA: Justification, Process, and Lessons Learned.
J Nucl Med. 2020;61:480-487.
PubMed Abstract available

GLASENAPP A, Derlin K, Wang Y, Bankstahl M, et al
Multimodality Imaging of Inflammation and Ventricular Remodeling in Pressure-Overload Heart Failure.
J Nucl Med. 2020;61:590-596.
PubMed Abstract available

BASTIAANNET R, van Roekel C, Smits MLJ, Elias SG, et al
First Evidence for a Dose-Response Relationship in Patients Treated with (166)Ho Radioembolization: A Prospective Study.
J Nucl Med. 2020;61:608-612.
PubMed Abstract available

PANDIT-TASKAR N, Postow MA, Hellmann MD, Harding JJ, et al
First-in-Humans Imaging with (89)Zr-Df-IAB22M2C Anti-CD8 Minibody in Patients with Solid Malignancies: Preliminary Pharmacokinetics, Biodistribution, and Lesion Targeting.
J Nucl Med. 2020;61:512-519.
PubMed Abstract available

WATABE T, Liu Y, Kaneda-Nakashima K, Shirakami Y, et al
Theranostics Targeting Fibroblast Activation Protein in the Tumor Stroma: (64)Cu- and (225)Ac-Labeled FAPI-04 in Pancreatic Cancer Xenograft Mouse Models.
J Nucl Med. 2020;61:563-569.
PubMed Abstract available

VAN WEEHAEGHE D, Van Schoor E, De Vocht J, Koole M, et al
TSPO Versus P2X7 as a Target for Neuroinflammation: An In Vitro and In Vivo Study.
J Nucl Med. 2020;61:604-607.
PubMed Abstract available

March 2020

WANG L, Wang M, Yang T, Wu D, et al
A Prospective, Comparative Study of Planar and Single-photon Emission Computed Tomography Ventilation/Perfusion Imaging for Chronic Thromboembolic Pulmonary Hypertension.
J Nucl Med. 2020 Mar 20. pii: jnumed.120.243188. doi: 10.2967/jnumed.120.243188.
PubMed Abstract available

DE JONG AC, Smits M, van Riet J, Futterer JJ, et al
(68)Ga-PSMA guided bone biopsies for molecular diagnostics in metastatic prostate cancer patients.
J Nucl Med. 2020 Mar 13. pii: jnumed.119.241109. doi: 10.2967/jnumed.119.241109.
PubMed Abstract available

COLLINGRIDGE D, Barthel H
A Conversation Between David Collingridge and Henryk Barthel.
J Nucl Med. 2020;61:307-310.
PubMed

ZHANG W, Fan W, Ottemann BM, Alshehri S, et al
Development of Improved Tumor-Residualizing, GRPR-Targeted Agents: Preclinical Comparison of an Endolysosomal Trapping Approach in Agonistic and Antagonistic Constructs.
J Nucl Med. 2020;61:443-450.
PubMed Abstract available

FLOBERG JM, Wang L, Bandara N, Rashmi R, et al
Alteration of Cellular Reduction Potential Will Change (64)Cu-ATSM Signal With or Without Hypoxia.
J Nucl Med. 2020;61:427-432.
PubMed Abstract available

WU J, Gensheimer MF, Zhang N, Guo M, et al
Tumor Subregion Evolution-Based Imaging Features to Assess Early Response and Predict Prognosis in Oropharyngeal Cancer.
J Nucl Med. 2020;61:327-336.
PubMed Abstract available

February 2020

HOPE TA, Bodei L, Chan JA, El-Haddad G, et al
NANETS/SNMMI Consensus Statement on Patient Selection and Appropriate Use of (177)Lu-DOTATATE Peptide Receptor Radionuclide Therapy.
J Nucl Med. 2020;61:222-227.
PubMed

CALAIS J
FAP: The Next Billion Dollar Nuclear Theranostics Target?
J Nucl Med. 2020;61:163-165.
PubMed

ANDERSEN TL, Baun C, Olsen BB, Dam JH, et al
Improving Contrast and Detectability: Imaging with [(55)Co]Co-DOTATATE in Comparison with [(64)Cu]Cu-DOTATATE and [(68)Ga]Ga-DOTATATE.
J Nucl Med. 2020;61:228-233.
PubMed Abstract available

CECCARINI J, Leurquin-Sterk G, Crunelle CL, de Laat B, et al
Recovery of Decreased Metabotropic Glutamate Receptor 5 Availability in Abstinent Alcohol-Dependent Patients.
J Nucl Med. 2020;61:256-262.
PubMed Abstract available

HENSBERGEN AW, Buckle T, van Willigen DM, Schottelius M, et al
Hybrid Tracers Based on Cyanine Backbones Targeting Prostate-Specific Membrane Antigen: Tuning Pharmacokinetic Properties and Exploring Dye-Protein Interaction.
J Nucl Med. 2020;61:234-241.
PubMed Abstract available

MILLER RJH, Manabe O, Tamarappoo B, Hayes S, et al
Comparative Prognostic and Diagnostic Value of Myocardial Blood Flow and Myocardial Flow Reserve After Cardiac Transplantation.
J Nucl Med. 2020;61:249-255.
PubMed Abstract available

MINARIK D, Enqvist O, Tragardh E
Denoising of Scintillation Camera Images Using a Deep Convolutional Neural Network: A Monte Carlo Simulation Approach.
J Nucl Med. 2020;61:298-303.
PubMed Abstract available

ZHANG X, Xie Z, Berg E, Judenhofer MS, et al
Total-Body Dynamic Reconstruction and Parametric Imaging on the uEXPLORER.
J Nucl Med. 2020;61:285-291.
PubMed Abstract available

KLINGENSMITH WC 3RD, Osborne JR
George de Hevesy in America.
J Nucl Med. 2020;61:304-305.
PubMed

ILAN E, Velikyan I, Sandstrom M, Sundin A, et al
Tumor-to-Blood Ratio for Assessment of Somatostatin Receptor Density in Neuroendocrine Tumors Using (68)Ga-DOTATOC and (68)Ga-DOTATATE.
J Nucl Med. 2020;61:217-221.
PubMed Abstract available

January 2020

POMPER MG, Choyke PL
Discussions with Leaders: A Conversation Between Martin Pomper and Peter Choyke.
J Nucl Med. 2020;61:3-5.
PubMed

WEBER WA, Bengel FM, Blasberg RG
The AQARA Principle: Proposing Standard Requirements for Radionuclide-Based Images in Medical Journals.
J Nucl Med. 2020;61:1-2.
PubMed

YOO SH, Kang SY, Cheon GJ, Oh DY, et al
Predictive Role of Temporal Changes in Intratumoral Metabolic Heterogeneity During Palliative Chemotherapy in Patients with Advanced Pancreatic Cancer: A Prospective Cohort Study.
J Nucl Med. 2020;61:33-39.
PubMed Abstract available

MAURER T, Graefen M, van der Poel H, Hamdy F, et al
Prostate-Specific Membrane Antigen-Guided Surgery.
J Nucl Med. 2020;61:6-12.
PubMed Abstract available

VAN LEEUWEN FWB, Schottelius M, Brouwer OR, Vidal-Sicart S, et al
Trending: Radioactive and Fluorescent Bimodal/Hybrid Tracers as Multiplexing Solutions for Surgical Guidance.
J Nucl Med. 2020;61:13-19.
PubMed Abstract available

PANTEL AR, Viswanath V, Daube-Witherspoon ME, Dubroff JG, et al
PennPET Explorer: Human Imaging on a Whole-Body Imager.
J Nucl Med. 2020;61:144-151.
PubMed Abstract available

CARLOS DOS SANTOS J, Beijer B, Bauder-Wust U, Schafer M, et al
Development of Novel PSMA Ligands for Imaging and Therapy with Copper Isotopes.
J Nucl Med. 2020;61:70-79.
PubMed Abstract available

KARP JS, Viswanath V, Geagan MJ, Muehllehner G, et al
PennPET Explorer: Design and Preliminary Performance of a Whole-Body Imager.
J Nucl Med. 2020;61:136-143.
PubMed Abstract available

December 2019

HERNANDEZ R, Grudzinski JJ, Aluicio-Sarduy E, Massey CF, et al
(177)Lu-NM600 targeted radionuclide therapy extends survival in syngeneic murine models of triple-negative breast cancer.
J Nucl Med. 2019 Dec 20. pii: jnumed.119.236265. doi: 10.2967/jnumed.119.236265.
PubMed Abstract available

ARNON-SHELEG E, Haberfeld O, Kremer R, Keidar Z, et al
Head to head prospective comparison of quantitative lung scintigraphy and segment counting in predicting pulmonary function of lung cancer patients undergoing video-assisted thoracoscopic lobectomy.
J Nucl Med. 2019 Dec 20. pii: jnumed.119.234526. doi: 10.2967/jnumed.119.234526.
PubMed Abstract available

MCDONALD ES, Doot RK, Young AJ, Schubert EK, et al
Breast Cancer (18)F-ISO-1 Uptake as a Marker of Proliferation Status.
J Nucl Med. 2019 Dec 13. pii: jnumed.119.232363. doi: 10.2967/jnumed.119.232363.
PubMed Abstract available

November 2019

MEERSHOEK P, Buckle T, van Oosterom MN, KleinJan GH, et al
Can fluorescence-guided surgery help identify all lesions in unknown locations or is the integrated use of a roadmap created by preoperative imaging mandatory? A blinded study in prostate cancer patients.
J Nucl Med. 2019 Nov 11. pii: jnumed.119.235234. doi: 10.2967/jnumed.119.235234.
PubMed Abstract available

HABERKORN U, Czernin J
A Conversation Between Uwe Haberkorn and Johannes Czernin.
J Nucl Med. 2019;60:1495-1498.
PubMed

SAADANI H, van der Hiel B, Aalbersberg EA, Zavrakidis I, et al
Metabolic Biomarker-Based BRAFV600 Mutation Association and Prediction in Melanoma.
J Nucl Med. 2019;60:1545-1552.
PubMed Abstract available

GARCIA EV, Slomka P, Moody JB, Germano G, et al
Quantitative Clinical Nuclear Cardiology, Part 1: Established Applications.
J Nucl Med. 2019;60:1507-1516.
PubMed Abstract available

PEREIRA PMR, Mandleywala K, Ragupathi A, Carter LM, et al
Temporal Modulation of HER2 Membrane Availability Increases Pertuzumab Uptake and Pretargeted Molecular Imaging of Gastric Tumors.
J Nucl Med. 2019;60:1569-1578.
PubMed Abstract available

KHERA E, Zhang L, Roberts S, Nessler I, et al
Blocking of Glucagonlike Peptide-1 Receptors in the Exocrine Pancreas Improves Specificity for beta-Cells in a Mouse Model of Type 1 Diabetes.
J Nucl Med. 2019;60:1635-1641.
PubMed Abstract available

September 2019

ROTTENBURGER C, Nicolas GP, McDougall L, Kaul F, et al
Cholecystokinin-2 Receptor Agonist (177)Lu-PP-F11N for Radionuclide Therapy of Medullary Thyroid Carcinoma - Results of the Lumed Phase 0a Study.
J Nucl Med. 2019 Sep 13. pii: jnumed.119.233031. doi: 10.2967/jnumed.119.233031.
PubMed Abstract available

GHAFOOR S, Burger IA, Vargas HA
Multimodality Imaging of Prostate Cancer.
J Nucl Med. 2019 Sep 3. pii: jnumed.119.228320. doi: 10.2967/jnumed.119.228320.
PubMed Abstract available

August 2019

VARASTEH Z, Mohanta S, Robu S, Braeuer M, et al
Molecular imaging of fibroblast activity after myocardial infarction using a (68)Ga-labelled fibroblast activation protein inhibitor FAPI-04.
J Nucl Med. 2019 Aug 12. pii: jnumed.119.226993. doi: 10.2967/jnumed.119.226993.
PubMed Abstract available

July 2019

Lawhn-Heath Named 2019 Henkin Fellow.
J Nucl Med. 2019;60:14N.
PubMed

DILSIZIAN V
SNMMI Leadership Update: Influx of New Ideas and Opportunities Collaboration Propels Growth.
J Nucl Med. 2019;60:13N.
PubMed

SEGALL GM
The Distinction Between an AU and an ABNM-Certified MD.
J Nucl Med. 2019;60:10N.
PubMed

HOPE TA, Abbott A, Colucci K, Bushnell DL, et al
NANETS/SNMMI Procedure Standard for Somatostatin Receptor-Based Peptide Receptor Radionuclide Therapy with (177)Lu-DOTATATE.
J Nucl Med. 2019;60:937-943.
PubMed Abstract available

REILLY RM
Immuno-PET to Optimize the Dose of Monoclonal Antibodies for Cancer Therapy: How Much Is Enough?
J Nucl Med. 2019;60:899-901.
PubMed

LUTJE S, Franssen GM, Herrmann K, Boerman OC, et al
In Vitro and In Vivo Characterization of an (18)F-AlF-Labeled PSMA Ligand for Imaging of PSMA-Expressing Xenografts.
J Nucl Med. 2019;60:1017-1022.
PubMed Abstract available

June 2019

NRC Advisory Committee on Medical Uses of Isotopes Spring Meeting.
J Nucl Med. 2019;60:19N.
PubMed

Outstanding JNMT Articles for 2018.
J Nucl Med. 2019;60:17N.
PubMed

Best JNM Articles for 2018.
J Nucl Med. 2019;60:16N.
PubMed

GREENSPAN BS, Ahuja S, Avram AM, Gulec S, et al
Overview of the Martinique Meetings: What Has Been Established and Where Are We Going?
J Nucl Med. 2019;60:15N.
PubMed

VOLKOW N, Czernin J
A Conversation Between Nora Volkow and Johannes Czernin.
J Nucl Med. 2019;60:717-720.
PubMed

MEERSHOEK P, van den Berg NS, Brouwer OR, Teertstra HJ, et al
Three-Dimensional Tumor Margin Demarcation Using the Hybrid Tracer Indocyanine Green-(99m)Tc-Nanocolloid: A Proof-of-Concept Study in Tongue Cancer Patients Scheduled for Sentinel Node Biopsy.
J Nucl Med. 2019;60:764-769.
PubMed Abstract available

EMMETT L, Metser U, Bauman G, Hicks RJ, et al
Prospective, Multisite, International Comparison of (18)F-Fluoromethylcholine PET/CT, Multiparametric MRI, and (68)Ga-HBED-CC PSMA-11 PET/CT in Men with High-Risk Features and Biochemical Failure After Radical Prostatectomy: Clinical Performance and P
J Nucl Med. 2019;60:794-800.
PubMed Abstract available

May 2019

SATHEKGE M, Bruchertseifer F, Vorster M, Lawal I, et al
PREDICTORS OF OVERALL AND DISEASE FREE SURVIVAL IN METASTATIC CASTRATION-RESISTANT PROSTATE CANCER PATIENTS RECEIVING (225)Ac-PSMA-617 RADIOLIGAND THERAPY.
J Nucl Med. 2019 May 17. pii: jnumed.119.229229. doi: 10.2967/jnumed.119.229229.
PubMed Abstract available

CARRASQUILLO JA, Fine B, Pandit-Taskar N, Larson SM, et al
Imaging metastatic castration-resistant prostate cancer patients with (89)Zr-DFO-MSTP2109A anti-STEAP1 antibody.
J Nucl Med. 2019 May 3. pii: jnumed.118.222844. doi: 10.2967/jnumed.118.222844.
PubMed Abstract available

FDA Updates Bulk Drug Substances List.
J Nucl Med. 2019;60:8N.
PubMed

SCHWAIGER M, Czernin J
A Conversation Between Markus Schwaiger and Johannes Czernin.
J Nucl Med. 2019;60:573-576.
PubMed

KELLY JM, Amor-Coarasa A, Ponnala S, Nikolopoulou A, et al
Albumin-Binding PSMA Ligands: Implications for Expanding the Therapeutic Window.
J Nucl Med. 2019;60:656-663.
PubMed Abstract available

April 2019

JANSEN BHE, Yaqub M, Voortman J, Cysouw MCF, et al
Simplified Methods for Quantification of (18)F-DCFPyL Uptake in Patients with Prostate Cancer.
J Nucl Med. 2019 Apr 18. pii: jnumed.119.227520. doi: 10.2967/jnumed.119.227520.
PubMed Abstract available

ABIODUN-OJO OA, Akintayo AA, Akin-Akintayo OO, Tade FI, et al
(18)F-Fluciclovine parameters on targeted prostate biopsy associated with true positivity in recurrent prostate cancer.
J Nucl Med. 2019 Apr 6. pii: jnumed.119.227033. doi: 10.2967/jnumed.119.227033.
PubMed Abstract available

March 2019

GEISLER S, Stegmayr C, Niemietz N, Lohmann P, et al
Treatment-related uptake of O-(2-[(18)F]fluoroethyl)-L-tyrosine and L-[methyl-(3)H]-methionine after tumor resection in rat glioma models.
J Nucl Med. 2019 Mar 8. pii: jnumed.119.225680. doi: 10.2967/jnumed.119.225680.
PubMed Abstract available

KRAMER GM, Yaqub M, Vargas HA, Schuit R, et al
Assessment of simplified methods for quantification of (18)F-FDHT uptake in patients with metastatic castration-resistant prostate cancer.
J Nucl Med. 2019 Mar 8. pii: jnumed.118.220111. doi: 10.2967/jnumed.118.220111.
PubMed Abstract available

February 2019

LIU T, Liu C, Xu X, Liu F, et al
Preclinical evaluation and pilot clinical study of Al(18)F-PSMA-BCH for prostate cancer imaging.
J Nucl Med. 2019 Feb 22. pii: jnumed.118.221671. doi: 10.2967/jnumed.118.221671.
PubMed Abstract available

November 2018

BEHR SC, Aggarwal R, Van Brocklin HF, Flavell RR, et al
First-in-Human Phase I study of CTT1057, a Novel (18)F Labeled Imaging Agent with Phosphoramidate Core Targeting Prostate Specific Membrane Antigen in Prostate Cancer.
J Nucl Med. 2018 Nov 21. pii: jnumed.118.220715. doi: 10.2967/jnumed.118.220715.
PubMed Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Nuclear Medicine is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: